http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 LONDON, November 19 /PRNewswire/ -- Research published today examining consumer opinions on counterfeit drugs reveals that five per cent of consumers across five European countries suspect they have... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4023 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4023 Thu, 19 Nov 2009 16:10:00 +0000 CAPE TOWN, South Africa, November 19 /PRNewswire/ -- Despite industry challenges, the rising consumer demand from developing industry sectors will drive exponential growth in the Nigerian contact... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4021 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4021 Thu, 19 Nov 2009 08:00:00 +0000 LONDON, November 18 /PRNewswire/ -- The biopesticides market in Western Europe and North America is growing strongly. The increasing demand for chemical-free crops, paralleled by the expansion of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4014 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4014 Wed, 18 Nov 2009 11:42:00 +0000 LONDON, November 18 /PRNewswire/ -- In the news release, "Mainstay of the Global Workforce - 40-65 Year Olds - Hit Hardest by Chronic Obstructive Pulmonary Disease (COPD)" issued on 18 Nov 2009... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4013 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4013 Wed, 18 Nov 2009 11:41:00 +0000 LONDON, November 18 /PRNewswire/ -- COPD Uncovered, a new report issued today reveals for the first time that people between the ages of 40 to 65 are emerging as the new face of this disease.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4007 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4007 Wed, 18 Nov 2009 06:30:00 +0000 KIEV, Ukraine, November 16 /PRNewswire/ -- The 6th International Christian Medical Conference was held at the President Hotel on October 30 and 31, 2009 under the auspices of Ukraine Organizing... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3990 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3990 Mon, 16 Nov 2009 09:50:00 +0000 LONDON, November 16 /PRNewswire/ -- The "omics" revolution of the last decade has ensured that the field of biomarker research will test the frontiers of biomedical research in the coming years. New... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3988 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3988 Mon, 16 Nov 2009 08:00:00 +0000 ORLANDO, Florida, November 15 /PRNewswire/ -- Results from the RecordAF registry (REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation), presented today at the Scientific... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3985 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3985 Sun, 15 Nov 2009 21:00:00 +0000 INDIANAPOLIS, November 13 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Steven M. Paul, M.D., executive vice president, science and technology, and president, Lilly Research... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3982 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3982 Fri, 13 Nov 2009 14:00:00 +0000 LONDON, November 13 /PRNewswire/ -- Around 20 per cent of plastic surgery patients are referred to psychologists due to unrealistic psychological expectations, according to cosmetic surgeons at... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3977 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3977 Fri, 13 Nov 2009 08:50:00 +0000 WILMINGTON, Delaware, November 12 /PRNewswire/ -- According to a new market research report, 'Service Outsourcing Opportunities in Medical Device Market (2009-2014)', published by MarketsandMarkets... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3972 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3972 Thu, 12 Nov 2009 10:23:00 +0000 LONDON, November 12 /PRNewswire/ -- The on-line journal Diabetic Hypoglycemia (http://www.hypodiab.com/) supports the message of World Diabetes Day 2009 ( http://www.worlddiabetesday.org) in their... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3968 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3968 Thu, 12 Nov 2009 00:01:00 +0000 LONDON, November 12 /PRNewswire/ -- The on-line journal Diabetic Hypoglycemia (http://www.hypodiab.com/) supports the message of World Diabetes Day 2009 (http://www.worlddiabetesday.org) in their... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3969 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3969 Thu, 12 Nov 2009 00:01:00 +0000 GENEVA, November 11 /PRNewswire/ -- Despite substantial progress, rates of child malnutrition in Bangladesh are among the highest in the world. More than 36 percent of preschool-age children are... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3967 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3967 Wed, 11 Nov 2009 23:00:00 +0000 LONDON, November 11 /PRNewswire/ -- The healthcare market is facing a severe downturn due to adverse effects of the global economic slowdown. Costs for healthcare are reaching unprecedented heights,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3965 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3965 Wed, 11 Nov 2009 09:00:00 +0000 LONDON, November 11 /PRNewswire/ -- It's official, everyone is getting ready for the Christmas Party Season. Research published this week from British Lion Eggs stated that 6 out of 10 women will be... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3960 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3960 Wed, 11 Nov 2009 06:30:00 +0000 LONDON, November 10 /PRNewswire/ -- Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3957 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3957 Tue, 10 Nov 2009 11:32:00 +0000 MAARSSEN, Netherlands, November 9 /PRNewswire/ -- Momentum is building for the early December staging in Mumbai of the third CPhI India and second P-MEC India pharma ingredients, services... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3953 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3953 Mon, 09 Nov 2009 21:00:00 +0000 ANDOVER, England, November 9 /PRNewswire/ -- As the UK's obesity crisis burgeons, millions of overweight Brits are blind to the fact that their unhealthy lifestyles mean they are twice as likely to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3947 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3947 Mon, 09 Nov 2009 00:01:00 +0000 LONDON, November 6 /PRNewswire/ -- Mouth cancer (also called oral cancer) is a malignant growth which can occur in any part of the mouth including the lips and tongue. In the UK, the numbers of new... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3943 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3943 Fri, 06 Nov 2009 13:24:00 +0000 PARIS, November 6 /PRNewswire/ -- Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3940 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3940 Fri, 06 Nov 2009 08:00:00 +0000 LONDON, November 5 /PRNewswire/ -- Breast enlargement operations performed as day case operations have soared in the past 15 years, seeing a whopping 235 per cent increase, UK cosmetic surgeons... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3935 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3935 Thu, 05 Nov 2009 07:55:00 +0000 LONDON, November 4 /PRNewswire/ -- Poverty and discrimination experienced by disabled people is on the rise, according to a survey conducted by Leonard Cheshire Disability. In its annual... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3930 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3930 Wed, 04 Nov 2009 13:53:00 +0000 LEUVEN, Belgium, November 4 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, is... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3926 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3926 Wed, 04 Nov 2009 06:30:00 +0000 WILMINGTON, Delaware, November 3 /PRNewswire/ -- The new market research report, 'Global Stem Cell and Advanced Technologies Market' (2009 - 2014)', published by... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3923 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3923 Tue, 03 Nov 2009 09:30:00 +0000 LONDON, November 3 /PRNewswire/ -- Twenga, the comprehensive shopping search engine, today reveals further results from its annual Christmas Spending Survey. The company asked over 3000 Europeans... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3922 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3922 Tue, 03 Nov 2009 07:30:00 +0000 NEWNAN, Georgia, October 31 /PRNewswire/ -- In the news release, French Physicians to Conduct 2000-Patient Study of CATANIA(TM) Coronary Stent, issued Oct. 30, 2009, by CeloNova BioSciences, Inc.,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3908 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3908 Sat, 31 Oct 2009 00:55:00 +0000 NEWNAN, Georgia, October 30 /PRNewswire/ -- Physicians at more than 40 centers in France have joined a study of the CATANIA(TM) Coronary Stent with NanoThin Polyzene(R)-F manufactured by CeloNova... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3906 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3906 Fri, 30 Oct 2009 18:55:00 +0000 LONDON, October 30 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) today announced preliminary results from a recently completed Phase III study with E7389... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3898 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3898 Fri, 30 Oct 2009 08:30:00 +0000 MILAN, October 29 /PRNewswire/ -- Mirial has just released a new whitepaper, An Interactive Visual Communication Architecture Proposal For Telehealth, which explains in details the benefits of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3894 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3894 Thu, 29 Oct 2009 12:58:00 +0000 LONDON, October 29 /PRNewswire/ -- In a frank commentary, pioneering surgeon to the courageous Katie Piper, Mr Mohammad Jawad discusses the next challenge he faces in the complex and vital ongoing... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3892 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3892 Thu, 29 Oct 2009 10:24:00 +0000 LONDON, October 28 /PRNewswire/ -- Even though no-one wants to admit it, the countdown to Christmas is upon us, and if you want to look good at the ubiquitous Christmas Party then follow the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3884 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3884 Wed, 28 Oct 2009 07:30:00 +0000 GLASGOW, October 27 /PRNewswire/ -- Big hearted staff at Kwik Fit Insurance held a charity benefit concert on Friday night for their charity of the year, Kidney Research UK. The event at 'The Ferry'... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3879 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3879 Tue, 27 Oct 2009 16:02:00 +0000 LONDON, October 27 /PRNewswire/ -- Microfluidics and lab-on-chip is a field with tremendous growth potential. As it is primarily an enabling technology, coupled with the fact that this is an era of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3875 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3875 Tue, 27 Oct 2009 10:00:00 +0000 STOCKHOLM, October 27 /PRNewswire/ -- Universum, the employer branding company, presents the world's Top 50 most attractive employers. From the world's leading economies, nearly 120,000 students at... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3874 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3874 Tue, 27 Oct 2009 09:00:00 +0000 PARIS, October 27 /PRNewswire/ -- Diabetic patients diagnosed with peripheral neuropathy had lower medical costs and reduced use of anticonvulsant medications when treated with a folate-enriched... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3873 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3873 Tue, 27 Oct 2009 06:00:00 +0000 LOUISVILLE, Kentucky, October 23 /PRNewswire/ -- -- Alcon takes over development of POT-4 as a treatment for patients with age-related macular degeneration -- Deal provides path for Alcon to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3858 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3858 Fri, 23 Oct 2009 13:00:00 +0000 PITTSBURGH, October 23 /PRNewswire/ -- Cohera Medical, Inc. announced today that it has received approval to begin human clinical trials of its lead product TissuGlu(R) in Germany. Receipt of the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3857 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3857 Fri, 23 Oct 2009 11:53:00 +0000 WILMINGTON, Delaware, October 22 /PRNewswire/ -- A new market research report, 'Global H1N1 2009 Influenza Vaccine', published by MarketsandMarkets (http://www.marketsandmarkets.com) analyzes the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3848 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3848 Thu, 22 Oct 2009 11:30:00 +0000 LONDON, October 21 /PRNewswire/ -- Research from Breastlight shows that women are confused about their actual risk of getting breast cancer. They also lack confidence when it comes to being breast... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3840 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3840 Wed, 21 Oct 2009 07:00:00 +0000 LONDON, October 20 /PRNewswire/ -- Interesting dynamics can be observed amongst communication service providers in Eastern Europe. The region is catching up on local loop unbundling, in tandem with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3834 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3834 Tue, 20 Oct 2009 11:24:00 +0000 LONDON, October 20 /PRNewswire/ -- The global recession will have limited effect on the lifesciences industry. However, internal factors and external issues such as weak product pipelines, generic... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3833 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3833 Tue, 20 Oct 2009 11:00:00 +0000 LONDON, October 19 /PRNewswire/ -- Over the last two decades, knee injuries have been on the rise among skiers in the French Alps. It is more likely for downhill skiers to experience a lower... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3825 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3825 Mon, 19 Oct 2009 19:25:00 +0000 NICE, France, October 19 /PRNewswire/ -- Preliminary findings from a new survey on electronic data capture (EDC) use in clinical trials were presented today at the Drug Information Association's... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3824 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3824 Mon, 19 Oct 2009 17:45:00 +0000 NYON, Switzerland, October 19 /PRNewswire/ -- The International Osteoporosis Foundation (IOF) will issue a new 16-page report on FRAX(R) to mark World Osteoporosis Day. The report is available... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3821 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3821 Mon, 19 Oct 2009 07:45:00 +0000 BELGRADE, Serbia, October 16 /PRNewswire/ -- Advances in cancer prevention and treatment reported at this week's premier European congress for specialists in gynaecological cancers show that care is... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3818 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3818 Fri, 16 Oct 2009 12:08:00 +0000 LONDON, October 15 /PRNewswire/ -- Don't wait until you go to hospital. That is the message emerging strongly from early results of a Survey by the Patients Association. The vital importance of clean... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3814 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3814 Thu, 15 Oct 2009 16:29:00 +0000 LONDON, October 15 /PRNewswire/ -- Brookdale Care, the specialist provider of care services for people living with autism, has today welcomed the House of Commons Public Accounts Committee's Report... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3809 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3809 Thu, 15 Oct 2009 00:01:00 +0000 LONDON, October 13 /PRNewswire/ -- Eastern Europe is poised to be the market to tap into in the near future for magnetic resonance imaging (MRI) manufacturers. These countries have budgets allocated... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3799 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3799 Tue, 13 Oct 2009 11:30:00 +0000 LONDON, October 13 /PRNewswire/ -- Up to 85 percent of technologies developed globally never see the commercial light of day because they founder in the so-called Valley of Death - the virtual chasm... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3797 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3797 Tue, 13 Oct 2009 09:42:00 +0000 LONDON, October 12 /PRNewswire/ -- Although cost efficiency is a major factor motivating pharmaceutical and biotechnology firms to outsource research, there is an increased emphasis on expertise and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3793 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3793 Mon, 12 Oct 2009 11:30:00 +0000 LONDON, October 12 /PRNewswire/ -- UK surgeons say the demand for larger implants has increased in the last decade, however, the experts say big is not always best. Roy Ng, cosmetic surgeon for... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3788 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3788 Mon, 12 Oct 2009 07:00:00 +0000 ZURICH, October 8 /PRNewswire/ -- EAACI, the largest European organisation in the field of allergy, immunology and asthma, today hosted a specialist forum on "Swine-flu - a threat for asthmatics?... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3781 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3781 Thu, 08 Oct 2009 10:32:00 +0000 LONDON, October 7 /PRNewswire/ -- The International Agency for the Prevention of Blindness (IAPB) has published a report to mark World Sight Day, which examines the current situation, and highlights... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3779 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3779 Wed, 07 Oct 2009 22:36:00 +0000 CAMBRIDGE, Massachusetts, October 6 /PRNewswire/ -- Mobile technology's low cost and ease of use make it ideal for improving the delivery of healthcare, education, and other social services in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3771 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3771 Tue, 06 Oct 2009 19:44:00 +0000 MOSCOW, October 6 /PRNewswire/ -- At the close of the 20th century, the lack of donor blood and the safety of blood medication became one of the most critical problems in the area of health... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3766 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3766 Tue, 06 Oct 2009 11:55:00 +0000 PRINCETON, New Jersey and LONDON, October 5 /PRNewswire/ -- Results from an 18-week phase 3b study in adults with type 2 diabetes with inadequate glycemic control on metformin therapy alone found... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3758 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3758 Mon, 05 Oct 2009 15:58:00 +0000 WILMINGTON, Delaware, September 30 /PRNewswire/ -- According to a new market research report, 'Neurostimulation Market', published by MarketsandMarkets (http://www.marketsandmarkets.com), the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3737 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3737 Wed, 30 Sep 2009 14:01:00 +0000 WILMINGTON, Delaware, September 30 /PRNewswire/ -- According to a new healthcare market research report 'Global Home Care and Self Care Market (2009 - 2014)', published by... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3736 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3736 Wed, 30 Sep 2009 14:00:00 +0000 BRUSSELS, September 29 /PRNewswire/ -- A new study today finds that musculoskeletal disorders (MSDs) account for nearly half (49%) of all absences from work and 60% of permanent work incapacity in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3731 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3731 Tue, 29 Sep 2009 23:01:00 +0000 WILMINGTON, September 29 /PRNewswire/ -- According to a new market research report, 'Probiotics... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3729 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3729 Tue, 29 Sep 2009 13:30:00 +0000 LONDON, September 28 /PRNewswire/ -- A recent Lancet article predicted a doubling of new cases of type 1 diabetes in European children aged under 5, and a 70% rise in cases in children under 15 years... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3725 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3725 Mon, 28 Sep 2009 07:00:00 +0000 COLLEGEVILLE, Pennsylvania, September 25 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the European Medicines Agency's (EMEA) Committee for Medicinal... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3719 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3719 Fri, 25 Sep 2009 16:32:00 +0000 SAN FRANCISCO, September 23 /PRNewswire/ -- Late-breaking data presented today from the COMPARE trial demonstrated that Abbott's (NYSE: ABT) market-leading XIENCE V(R) Everolimus Eluting Coronary... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3705 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3705 Wed, 23 Sep 2009 22:08:00 +0000 SAN FRANCISCO, September 22 /PRNewswire/ -- Twelve-month data from EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) study high-risk registry arm presented today at the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3694 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3694 Tue, 22 Sep 2009 20:00:00 +0000 THOUSAND OAKS, California, September 22 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3690 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3690 Tue, 22 Sep 2009 11:55:00 +0000 LONDON, September 22 /PRNewswire/ -- New research shows that 85% of UK's leaders demonstrate 'Dark Side Characteristics'. These deeply rooted, self-destructive aspects of personality contribute to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3689 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3689 Tue, 22 Sep 2009 10:39:00 +0000 MAIDENHEAD, England, September 22 /PRNewswire/ -- Actress, artist and activist Jane Seymour will host the first My Day for RA European event in Barcelona, Spain this evening to recognise the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3683 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3683 Tue, 22 Sep 2009 08:00:00 +0000 FRANKFURT, September 21 /PRNewswire/ -- Trying economic times mean tight budgets. More projects, fewer people, rigid quality standards and competitve pressures are making the computer-driven... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3682 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3682 Mon, 21 Sep 2009 17:55:00 +0000 NEW YORK, September 21 /PRNewswire/ -- More than 35 million people worldwide will have dementia in 2010, according to the 2009 World Alzheimer's Report from Alzheimer's Disease International (ADI).... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3672 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3672 Mon, 21 Sep 2009 05:01:00 +0000 ANTWERP, Belgium, September 17 /PRNewswire/ -- A coalition of influential European advocacy and professional groups are meeting today to call for action by the European Parliament to commit... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3668 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3668 Fri, 18 Sep 2009 08:00:00 +0000 TONBRIDGE, England, September 17 /PRNewswire/ -- The Contraceptive Pill has been crowned the greatest pharmacy innovation of the past 150 years, by leading figures in the drugs industry. The... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3666 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3666 Thu, 17 Sep 2009 16:00:00 +0000 LONDON, September 17 /PRNewswire/ -- Power Plate International Limited, the leader in Acceleration Training(TM) exercise equipment, today received certification as a Medical Device Manufacturer... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3663 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3663 Thu, 17 Sep 2009 08:00:00 +0000 CAMBRIDGE, England, September 16 /PRNewswire/ -- This week, 59 undergraduates with diverse cultural and educational backgrounds will meet at the University of Cambridge for the first Amgen Scholars... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3650 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3650 Wed, 16 Sep 2009 10:16:00 +0000 ANDOVER, England, September 16 /PRNewswire/ -- Despite the economic downturn, companies are more than doubling their spend on healthcare benefits, according to new research from Simplyhealth's... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3646 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3646 Tue, 15 Sep 2009 14:29:00 +0000 ANDOVER, England, September 15 /PRNewswire/ -- Over half of people living in Britain are so scared of losing their job in the current climate that they are risking their health by working through... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3645 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3645 Tue, 15 Sep 2009 14:02:00 +0000 CAPE TOWN, South Africa, September 15 /PRNewswire/ -- Ghana's healthcare industry is experiencing growth across a range of sectors. However, the drive towards improved diagnostic capability has led... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3638 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3638 Tue, 15 Sep 2009 09:00:00 +0000 GENEVA, September 14 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the results of the RebiSmart(TM) user trial, a Phase IIIb, multi-center, single-arm... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3633 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3633 Mon, 14 Sep 2009 16:52:00 +0000 LONDON, September 14 /PRNewswire/ -- The market potential for patient monitoring solutions has largely remained untapped, while the demand that potentially exists is significant. Ageing baby boomers... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3629 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3629 Mon, 14 Sep 2009 13:40:00 +0000 DENVER, September 14 /PRNewswire/ -- The International Osteoporosis Foundation (IOF) today announced results from a new multinational survey of patients (n= 844; women 55+ with post menopausal... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3624 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3624 Mon, 14 Sep 2009 05:00:00 +0000 LISBON, Portugal, September 9 /PRNewswire/ -- In the news release, "First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain" issued on 9 Sep... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3614 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3614 Thu, 10 Sep 2009 17:26:00 +0000 LONDON, September 10 /PRNewswire/ -- Modelling carried out by Milliman actuaries estimates that a severe swine flu pandemic has the potential to reduce a typical UK employer's revenue by 4%-5% and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3609 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3609 Thu, 10 Sep 2009 08:00:00 +0000 EUROPEAN FEDERATION OF CHAPTERS OF THE INTERNATIONAL ASSOCIATION FOR THE STUDY OF PAIN (EFIC) CONGRESS, LISBON, September 10 /PRNewswire/ -- 95% of patients are suffering from moderate to severe... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3606 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3606 Thu, 10 Sep 2009 00:18:00 +0000 LISBON, Portugal, September 9 /PRNewswire/ -- The first results of the first European survey of cancer patients' experience of breakthrough pain[1] were presented today at the 6th congress of the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3597 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3597 Wed, 09 Sep 2009 08:00:00 +0000 LONDON, September 9 /PRNewswire/ -- Have you ever thought about what you want to do before you die? The 2007 film The Bucket List highlighted this with Jack Nicholson, and Morgan Freeman. With the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3596 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3596 Wed, 09 Sep 2009 07:30:00 +0000 CAMBRIDGE, Massachusetts, September 8 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, is committed to doing everything possible to assist Gaucher... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3593 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3593 Tue, 08 Sep 2009 12:00:00 +0000 LONDON, September 8 /PRNewswire/ -- New research results, which delve into the mind of smokers, are launched today, lifting the veil of nicotine addiction to understand the thoughts, anxieties and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3589 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3589 Tue, 08 Sep 2009 00:01:00 +0000 LONDON, September 7 /PRNewswire/ -- Bounty, the UK's favourite parenting club, today launches a 4 minute 'How to Breastfeed' online video clip to help expectant and new mums take a real life, close... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3585 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3585 Mon, 07 Sep 2009 10:00:00 +0000 CHICAGO, September 7 /PRNewswire/ -- OAG, the leading provider of global airline data and intelligence, has developed a prototype to assist health organizations and government agencies in preparing... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3582 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3582 Mon, 07 Sep 2009 07:00:00 +0000 LONDON, September 4 /PRNewswire/ -- The Nielsen Company today announced it received the award for "Most Innovative Approach" from the British Healthcare Business Intelligence Association for creating... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3580 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3580 Fri, 04 Sep 2009 17:30:00 +0000 NEWBURY, England, September 5 /PRNewswire/ -- Women's health experts are warning that old wives' tales and ignorance about modern contraceptive options could be fuelling Britain's high levels... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3581 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3581 Fri, 04 Sep 2009 11:08:00 +0000 TONBRIDGE, England, September 3 /PRNewswire/ -- Thousands of frontline health workers in England are trapped in a postcode lottery after Department of Health (DH) guidance on swine flu vaccination... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3577 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3577 Thu, 03 Sep 2009 16:12:00 +0000 LONDON, September 3 /PRNewswire/ -- The results of a new survey, launched today by the UK MDS Patient Support Group, shows that almost a fifth (18 percent) of patients suffering from myelodysplastic... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3571 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3571 Thu, 03 Sep 2009 05:00:00 +0000 WILMINGTON, Delaware, September 2 /PRNewswire/ -- According to a new market research report, 'Global Emerging Lighting Technologies Market (2009-2014)', published by... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3568 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3568 Wed, 02 Sep 2009 13:30:00 +0000 WILMINGTON, Delaware, September 2 /PRNewswire/ -- According to a new healthcare market research report 'Global Top Minimally Invasive/Non Invasive Market (2009 - 2014)', published... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3569 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3569 Wed, 02 Sep 2009 13:30:00 +0000 WILMINGTON, Delaware, September 2 /PRNewswire/ -- According to a new market research report, 'Global biosimilars Market (2009 - 2014)', published by MarketsandMarkets... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3570 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3570 Wed, 02 Sep 2009 13:30:00 +0000 LONDON, September 2 /PRNewswire/ -- Although most hospitals in Europe have some kind of information system in place, very few have a fully integrated and functional hospital information systems (HIS)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3565 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3565 Wed, 02 Sep 2009 11:00:00 +0000 BARCELONA, September 1 /PRNewswire/ -- Low levels of high-density lipoprotein cholesterol (HDL-C) and raised triglycerides, affecting millions of patients worldwide, are strongly linked to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3559 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3559 Tue, 01 Sep 2009 13:30:00 +0000 WILMINGTON, Delaware, September 1 /PRNewswire/ -- The Global Biomarker Market report analyzes the biomarker tools and services market over the period 2009-2014. The report studies the major market... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3555 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3555 Tue, 01 Sep 2009 11:16:00 +0000 WILMINGTON, Delaware, September 1 /PRNewswire/ -- According to a new market research report, 'Global biomaterials Market (2009-2014)', published by MarketsandMarkets... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3553 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3553 Tue, 01 Sep 2009 10:44:00 +0000 WILMINGTON, Delaware, September 1 /PRNewswire/ -- According to a new market research report, 'Global Autoimmune Treatment Market (2009-2014)', published by MarketsandMarkets... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3552 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3552 Tue, 01 Sep 2009 10:43:00 +0000 MONT-SAINT-GUIBERT, Belgium, August 31 /PRNewswire/ -- Cardio3 BioSciences, today provided an update and review of the clinical development of its unique C-Cure(R) therapy at the European Society of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3546 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3546 Mon, 31 Aug 2009 17:30:00 +0000 BARCELONA, Spain, August 31 /PRNewswire/ -- Eight out of 10 heart patients in an international survey of more than 3,000 patients felt their heart disease diagnosis was a wake-up call to live a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3545 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3545 Mon, 31 Aug 2009 15:30:00 +0000 PARIS, August 31 /PRNewswire/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3539 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3539 Mon, 31 Aug 2009 09:34:00 +0000 HOOFDDORP, The Netherlands, August 31 /PRNewswire/ -- The world of running is experiencing a 'second running wave', with approximately 36% of 15 to 65 year-old Europeans taking to the streets, parks,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3538 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3538 Mon, 31 Aug 2009 09:00:00 +0000 BARCELONA, Spain, August 31 /PRNewswire/ -- The Thrombosis Research Institute (TRI) - an affiliated institute of Queen Mary University of London - today announced the launch of GARFIELD (Global... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3535 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3535 Mon, 31 Aug 2009 05:01:00 +0000 LONDON, August 31 /PRNewswire/ -- Scientists have discovered a blood test that could predict the course of multiple sclerosis (MS), or even indicate who is likely to develop the condition after a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3533 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3533 Mon, 31 Aug 2009 01:32:00 +0000 BARCELONA, Spain, August 30 /PRNewswire/ -- The Thrombosis Research Institute (TRI) - a charitable foundation and affiliated institute of Queen Mary University of London - today announced the launch... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3530 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3530 Sun, 30 Aug 2009 05:01:00 +0000 LONDON, August 28 /PRNewswire/ -- There has been a significant increase in parents testing positive to drugs when required to undergo a hair test in child custody cases, according to the latest... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3529 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3529 Fri, 28 Aug 2009 10:39:00 +0000 INGELHEIM, Germany, August 28 /PRNewswire/ -- A new analysis of the landmark UPLIFT(R) trial, published today in the Lancet, shows that tiotropium (SPIRIVA(R) Handihaler(R) 18 micro g) administered... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3526 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3526 Fri, 28 Aug 2009 00:01:00 +0000 LONDON, August 27 /PRNewswire/ -- A new research study carried out by The Research Partnership reveals that living with diabetes can have a major effect on people's lives, with just under half (44%)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3522 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3522 Thu, 27 Aug 2009 10:00:00 +0000 LONDON, August 26 /PRNewswire/ -- Following the tragic death of Michael Jackson and the recent news that high levels of the potent anaesthetic propofol were found in his body, the fans of Michael... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3517 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3517 Wed, 26 Aug 2009 14:58:00 +0000 LONDON, August 26 /PRNewswire/ -- Travelzoo (NASDAQ: TZOO), a global Internet media company, today announced the results of a pan-European survey conducted last week among 10,582 travellers in 24... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3514 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3514 Wed, 26 Aug 2009 07:45:00 +0000 WILMINGTON, Delaware, August 25 /PRNewswire/ -- According to a new healthcare market research report 'Global Top Ten Medical Device Technologies Market (2009 - 2014)', published by MarketsandMarkets... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3508 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3508 Tue, 25 Aug 2009 10:30:00 +0000 LONDON, August 24 /PRNewswire/ -- The MS Society, the UK's largest charity dedicated to supporting everyone affected by multiple sclerosis (MS), has responded to the news issued by the University of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3504 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3504 Mon, 24 Aug 2009 15:09:00 +0000 TONBRIDGE, England, August 21 /PRNewswire/ -- Pharmacists have branded government swine flu vaccination plans "unacceptable," Chemist+Druggist has revealed. The criticism comes after the profession... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3495 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3495 Fri, 21 Aug 2009 16:00:00 +0000 TONBRIDGE, England, August 21 /PRNewswire/ -- Medicine shortages have left patients extremely distressed, with some seeing their conditions deteriorate and even being admitted to hospital,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3496 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3496 Fri, 21 Aug 2009 16:00:00 +0000 LONDON, August 19 /PRNewswire/ -- Increasing knowledge related to the pathology of diabetes will support the introduction of improved drugs to treat the disease. As healthcare moves towards the ideal... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3489 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3489 Wed, 19 Aug 2009 10:30:00 +0000 LONDON, August 19 /PRNewswire/ -- The Work Foundation, RAND Europe and Aston Business School - the partnership trio of research organisations working closely with the review team to undertake the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3488 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3488 Wed, 19 Aug 2009 10:00:00 +0000 LONDON, August 13 /PRNewswire/ -- As the prevalence of Type 2 diabetes continues to rise significantly, with over 125,000 new cases diagnosed a year(1), new survey results show that those affected... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3466 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3466 Thu, 13 Aug 2009 07:00:00 +0000 MENLO PARK, California, August 13 /PRNewswire/ -- Data published today in the Journal of the American College of Cardiology (JACC) indicates that percutaneous valve repair with the MitraClip(R)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3464 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3464 Thu, 13 Aug 2009 01:47:00 +0000 LONDON, August 12 /PRNewswire/ -- Commenting on last night's BBC Three documentary which followed the lives of three young people living with Autism and Asperger syndrome ('The Autistic Me', BBC... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3463 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3463 Wed, 12 Aug 2009 15:25:00 +0000 LONDON, August 12 /PRNewswire/ -- The challenge to manage adverse events in an optimal and efficient way and, at the same time, adhere to regulatory requirements has dictated the need for cutting... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3461 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3461 Wed, 12 Aug 2009 10:30:00 +0000 LONDON, August 5 /PRNewswire/ -- As the modern enterprise seeks to focus ever more narrowly on its core activities, IT outsourcing services are increasingly being considered as a business strategy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3446 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3446 Wed, 05 Aug 2009 14:30:00 +0000 BOULDER, Colorado, August 5 /PRNewswire/ -- The following is being issued by The Organic Center -- We (The Organic Center) strongly refute the claim made by Dr. Alan Dangour and his U.K. colleagues... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3444 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3444 Wed, 05 Aug 2009 13:30:00 +0000 LONDON, July 31 /PRNewswire/ -- It's been a year since fashion designer Joanne Scott went through a cancer treatment that changed her life -- and made history to boot. Ms Scott, 54, was the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3426 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3426 Fri, 31 Jul 2009 00:05:00 +0000 TOKYO, July 30 /PRNewswire/ -- With a business plan to launch 8-10 new products each year, Nippon Universal Pharmaceutical Co. Ltd., a subsidiary of the Zydus group, one of India's leading integrated... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3423 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3423 Thu, 30 Jul 2009 09:41:00 +0000 LONDON, July 29 /PRNewswire/ -- New research released today by the Royal Pharmaceutical Society of Great Britain (RPSGB) reveals how older people are taking a cocktail of medicine without fully... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3419 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3419 Tue, 28 Jul 2009 11:51:00 +0000 LONDON, July 28 /PRNewswire/ -- In order to increase productivity, healthcare providers have started to integrate many IT-based ancillary systems such as EMR, HIS and PACS. So far, this has purely... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3414 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3414 Tue, 28 Jul 2009 10:00:00 +0000 WILMINGTON, Delaware, July 28 /PRNewswire/ -- According to a new market research report, 'Drug-Device Combination Market (2009 - 2014)', published by MarketsandMarkets... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3415 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3415 Tue, 28 Jul 2009 10:00:00 +0000 GOTHENBURG, Sweden, July 22 /PRNewswire/ -- Cellectricon, a leading provider of cell-based screening solutions for research and drug discovery, today announced its collaboration with University of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3396 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3396 Wed, 22 Jul 2009 07:00:00 +0000 WASHINGTON, July 21 /PRNewswire/ -- Clinical trials conducted in the developing world meet the same safety, ethical and quality standards as those conducted in the developed world. That is the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3394 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3394 Tue, 21 Jul 2009 13:00:00 +0000 LONDON, July 21 /PRNewswire/ -- Europe's aging population has led to a rise in the number of registrations and diagnoses of respiratory diseases. While there has been a shift towards non-invasive... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3393 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3393 Tue, 21 Jul 2009 10:00:00 +0000 CAPE TOWN, South Africa, July 21 /PRNewswire/ -- Adverse economic conditions, the rising cost of healthcare and decreased donor funding to sub-Saharan Africa are posing major challenges to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3392 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3392 Tue, 21 Jul 2009 09:00:00 +0000 LONDON, July 20 /PRNewswire/ -- There has been a recent upsurge in Merger & Acquisition (M&A) activities in the pharmaceutical and biotechnology space. While the economic downturn and related... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3390 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3390 Mon, 20 Jul 2009 10:00:00 +0000 ROCKVILLE, Maryland and LONDON, July 20 /PRNewswire/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) today announced that BENLYSTA(TM) (belimumab, formerly... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3388 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3388 Mon, 20 Jul 2009 05:01:00 +0000 BOSTON and EDISON, New Jersey, July 15 /PRNewswire/ -- -- Pharmacokinetic Analysis of Atrial Fibrillation Study May Explain Bleeding Rate Difference between Once-Daily and Twice-Daily Dosing... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3373 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3373 Wed, 15 Jul 2009 13:30:00 +0000 LONDON, July 15 /PRNewswire/ -- realbuzz.com is here to ensure that you have everything you could possibly need to live a healthy, active life and we've been looking at the most popular diets. So,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3371 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3371 Wed, 15 Jul 2009 07:30:00 +0000 NEW YORK, July 14 /PRNewswire/ -- More than 90% of consumers across the five major European markets -- the UK, France, Italy, Germany and Spain -- share an interest in health, according to a new... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3367 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3367 Tue, 14 Jul 2009 17:06:00 +0000 TIRAT CARMEL, Israel, July 14 /PRNewswire/ -- InSightec Ltd. today announced that a team at the University Children's Hospital Zurich has completed a feasibility study testing the use of non-invasive... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3358 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3358 Tue, 14 Jul 2009 08:35:00 +0000 LONDON, July 13 /PRNewswire/ -- The market for most medical imaging devices is at a mature phase. Most unit shipment sales are geared towards the replacement of older systems. Global conglomerates,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3353 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3353 Mon, 13 Jul 2009 12:28:00 +0000 VIENNA, July 13 /PRNewswire/ -- A new study presented today at a major International medical meeting reveals that approximately two-thirds of physicians in the United Kingdom, France, Italy, Spain... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3349 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3349 Mon, 13 Jul 2009 07:00:00 +0000 RUSHDEN, England, July 10 /PRNewswire/ -- A comprehensive study released today by The Consulting Practice at Bright Horizons Family Solutions confirms the importance of employer-supported child care... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3346 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3346 Fri, 10 Jul 2009 10:00:00 +0000 LONDON, July 8 /PRNewswire/ -- Divorcing parents who embark on a hedonistic lifestyle are in danger of losing custody of their children thanks to a growing trend in hair test requests to gauge how... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3342 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3342 Wed, 08 Jul 2009 12:41:00 +0000 LONDON, July 7 /PRNewswire/ -- The 2008 Frost & Sullivan Global Food and Beverage Prebiotics Product Innovation Award is presented to Ireland-based Marigot Ltd. and U.S.-based GTC Nutrition for... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3339 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3339 Tue, 07 Jul 2009 12:29:00 +0000 LONDON, July 7 /PRNewswire/ -- The medical device industry is one of the most vital and dynamic sectors of the European economy. The industry is constantly driven by R&D, which needs to keep pace... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3338 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3338 Tue, 07 Jul 2009 11:37:00 +0000 LONDON, July 7 /PRNewswire/ -- With the first innings of the Ashes commencing this week, celebrity TV presenter and former England cricketer and spin ace, Phil Tufnell is calling on British blokes to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3336 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3336 Tue, 07 Jul 2009 08:00:00 +0000 LONDON, July 6 /PRNewswire/ -- Healthcare in Europe is increasingly becoming digitised and there is growing need to develop and deploy sophisticated information systems. However, the wireless... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3331 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3331 Mon, 06 Jul 2009 12:00:00 +0000 LONDON, July 2 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3324 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3324 Thu, 02 Jul 2009 17:20:00 +0000 LONDON, July 1 /PRNewswire/ -- On June 11, the National Institute for Health and Clinical Excellence (NICE) announced that, following consultation with stakeholders on the economic model that... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3316 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3316 Wed, 01 Jul 2009 13:38:00 +0000 LONDON, June 30 /PRNewswire/ -- Health systems should have bigger incentives and rewards for innovators - according to a panel of European healthcare experts. Healthcare systems are large,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3306 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3306 Tue, 30 Jun 2009 13:52:00 +0000 LUGANO, Switzerland, June 30 /PRNewswire/ -- About Palonosetron (Aloxi(R), Onicit(R), Paloxi(R)) Palonosetron (palonosetron hydrochloride) is a selective 5-HT3 receptor antagonist, developed for... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3307 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3307 Tue, 30 Jun 2009 13:52:00 +0000 LONDON, June 30 /PRNewswire/ -- Wireless technologies has been of immense value to medical practitioners, enabling them to increase productivity and improve the availability of quality healthcare... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3305 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3305 Tue, 30 Jun 2009 11:39:00 +0000 LONDON, June 30 /PRNewswire/ -- Governments across the globe are looking for new and sophisticated technologies to combat rising crime and terrorism. Recent advancements in biometric technology... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3304 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3304 Tue, 30 Jun 2009 11:11:00 +0000 LONDON, June 30 /PRNewswire/ -- Two-dimensional electrophoresis (2DE) is the most cost-effective protein profiling technology and is the only technology in which the constituents of a protein sample... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3303 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3303 Tue, 30 Jun 2009 10:26:00 +0000 AMSTERDAM, June 29 /PRNewswire/ -- Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced the highlights of its journal impact factor... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3298 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3298 Mon, 29 Jun 2009 12:53:00 +0000 LONDON, June 29 /PRNewswire/ -- The Healthcare Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the European Hospital Information Systems (HIS)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3297 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3297 Mon, 29 Jun 2009 12:00:00 +0000 BRUSSELS and INNSBRUCK, Austria, June 26 /PRNewswire/ -- One of the questions the European Health Technology Institute for Socio-Economic Research (EHTI) hopes to answer is whether national... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3287 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3287 Fri, 26 Jun 2009 09:15:00 +0000 AMSTERDAM, June 25 /PRNewswire/ -- Elsevier, a world-leading publisher of scientific, technical and medical information products and services, today announced results of its SciVal Spotlight... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3281 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3281 Thu, 25 Jun 2009 15:12:00 +0000 ANDOVER, England, June 24 /PRNewswire/ -- Raman Sankaran, Sales and Marketing Director for Simplyhealth comments on the Independent Review of NHS Dentistry in England. "The long awaited... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3275 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3275 Wed, 24 Jun 2009 14:55:00 +0000 LONDON, June 24 /PRNewswire/ -- Pulse oximetry is often referred to as the fifth vital sign. The significance of continuous oxygenation monitoring in hospitals and other critical care settings cannot... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3274 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3274 Wed, 24 Jun 2009 10:32:00 +0000 CHARLOTTESVILLE, Virginia, June 24 /PRNewswire/ -- Biovista Inc. today announced that BVA-601, its small-molecule drug targeting epilepsy, has shown positive results in the Kainic acid murine model... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3269 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3269 Wed, 24 Jun 2009 09:00:00 +0000 BASINGSTOKE, England, June 24 /PRNewswire/ -- As National Falls Awareness Day takes place this week, a new programme called 'Be Active' is being launched to help those already prescribed bone health... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3272 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3272 Wed, 24 Jun 2009 09:00:00 +0000 LONDON, June 24 /PRNewswire/ -- How happy are you? Would you like to be happier? Join TopTips.com's Campaign for Happiness and watch your daily happiness soar! What is it? http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3267 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3267 Wed, 24 Jun 2009 08:00:00 +0000 LONDON, June 23 /PRNewswire/ -- The European diabetes diagnostics market is poised for expansion with segments such as self-monitoring and point-of-care (POC) tests offering tremendous growth... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3262 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3262 Tue, 23 Jun 2009 10:25:00 +0000 LONDON, June 18 /PRNewswire/ -- The Bone Cancer Research Trust is calling for new treatments for bone cancers affecting children and young people. This includes osteosarcoma and Ewing's sarcoma, the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3246 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3246 Thu, 18 Jun 2009 15:46:00 +0000 DUBLIN, June 18 /PRNewswire/ -- According to a report issued today, drug safety leaders in pharmaceutical and biotechnology companies recognise the need to increase resources, either internally or... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3241 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3241 Thu, 18 Jun 2009 08:00:00 +0000 LONDON, June 17 /PRNewswire/ -- Diagnostic display monitors experienced slow growth in 2007 due to picture archiving and communication system (PACS) installations across radiology departments of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3230 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3230 Wed, 17 Jun 2009 10:30:00 +0000 LONDON, June 17 /PRNewswire/ -- With summer getting ever closer it's time to lose the tights and ditch the cover-up cardigans. But if the thought of having to show your legs and bare your midriff is... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3229 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3229 Wed, 17 Jun 2009 08:00:00 +0000 EVANSTON, Illinois, June 16 /PRNewswire/ -- Despite rampant downsizing in the pharmaceutical industry, pharmaceutical companies in Europe cannot rely solely on sales force reductions to drive future... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3226 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3226 Tue, 16 Jun 2009 13:00:00 +0000 UTRECHT, Netherlands, June 15 /PRNewswire/ -- The largest worldwide investigation into connection, carried out in 14 countries among 10,000 respondents, indicates that strongly connected people have... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3212 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3212 Mon, 15 Jun 2009 08:50:00 +0000 LONDON, June 12 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3209 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3209 Fri, 12 Jun 2009 13:45:00 +0000 COPENHAGEN, June 12 /PRNewswire/ -- Researchers, doctors and patient groups will today call on rheumatologists and related healthcare professionals to view their patients as productive workers and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3202 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3202 Fri, 12 Jun 2009 00:01:00 +0000 NOIDA, India, June 11 /PRNewswire/ -- Jubilant Organosys Ltd., headquartered in Noida, announced today that its Bangalore-based subsidiary, Jubilant Biosys Ltd., has entered into a discovery and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3200 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3200 Thu, 11 Jun 2009 13:34:00 +0000 COLLEGEVILLE, Pennsylvania, June 11 /PRNewswire/ -- New data from Phase 3 European clinical trials reinforce that Wyeth's (NYSE: WYE) investigational pneumococcal vaccine, Prevenar 13* (Pneumococcal... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3198 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3198 Thu, 11 Jun 2009 12:00:00 +0000 ANDOVER, England, June 11 /PRNewswire/ -- Despite making cut backs in many areas, employers remain committed to looking after their people. Spend on employee healthcare benefits, in the form of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3197 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3197 Thu, 11 Jun 2009 11:54:00 +0000 LONDON, June 10 /PRNewswire/ -- Information released this week by the British Association of Aesthetic Plastic Surgeons (BAAPS) highlights their concerns over permanent fillers. Q-Med, the leading... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3191 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3191 Wed, 10 Jun 2009 16:38:00 +0000 LUDWIGSHAFEN, Germany, June 10 /PRNewswire/ -- It doesn't take long after you've polished off a plateful of the delicious vegetable before you are forcefully reminded of it in the restroom. Some... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3188 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3188 Wed, 10 Jun 2009 11:53:00 +0000 LONDON, June 9 /PRNewswire/ -- ChemGenex Pharmaceuticals Limited (ASX:CXS) announced that positive, updated data from its phase 2/3 clinical trial study of omacetaxine in chronic myeloid leukemia... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3184 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3184 Tue, 09 Jun 2009 17:54:00 +0000 CAPE TOWN, South Africa, June 9 /PRNewswire/ -- The medical imaging market in Kenya is set for steady growth over the next five years, driven by an aging population demanding greater access... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3180 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3180 Tue, 09 Jun 2009 09:00:00 +0000 LONDON, June 8 /PRNewswire/ -- Survey Shows Many Doctors Find the Management of Atrial Fibrillation Difficult and Patients are Unaware of the Risks, Complexities and Treatment for This Most Common of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3171 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3171 Mon, 08 Jun 2009 07:30:00 +0000 LONDON, June 5 /PRNewswire/ -- Brookdale Care, the specialist provider of care services for people living with autism, has today welcomed the National Audit Office's Report on Supporting Adults with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3167 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3167 Fri, 05 Jun 2009 17:20:00 +0000 LONDON, June 5 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3164 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3164 Fri, 05 Jun 2009 08:00:00 +0000 LONDON, June 4 /PRNewswire/ -- The latest issue of the online journal Diabetic Hypoglycemia (http://www.hypodiab.com) features an authoritative review on sulfonylureas by Professor Ian Campbell, a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3161 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3161 Thu, 04 Jun 2009 13:33:00 +0000 LONDON, June 4 /PRNewswire/ -- Millions of Brits are dicing with disaster and placing their health at risk when taking overseas holidays, research from the Royal Pharmaceutical Society of Great... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3159 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3159 Thu, 04 Jun 2009 00:01:00 +0000 JERUSALEM, June 3 /PRNewswire/ -- The Gamida Cell-Teva Joint Venture announced today that five prestigious cord blood transplantations centers in Spain, three in Barcelona and two in Valencia, have... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3155 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3155 Wed, 03 Jun 2009 15:35:00 +0000 PARIS and BRISBANE, California, June 3 /PRNewswire/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and its fully owned subsidiary, BiPar Sciences, today announced results from a randomized Phase 2... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3156 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3156 Wed, 03 Jun 2009 15:35:00 +0000 LONDON, June 2 /PRNewswire/ -- The demand for more user-friendly healthcare IT professional services has been increasing across Europe. Companies that have delivered the right blend of 360 degree... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3151 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3151 Tue, 02 Jun 2009 13:30:00 +0000 CHICAGO, June 2 /PRNewswire/ -- Data from 7 prucalopride trials are being presented at the Digestive Disease Week (DDW) in Chicago. They confirm the consistent and predictable efficacy of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3150 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3150 Tue, 02 Jun 2009 11:35:00 +0000 SYDNEY, June 2 /PRNewswire/ -- A study published in the latest edition of Bulletin of the World Health Organisation (June 2009) estimates the global economy loses $269 billion(1) in productivity... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3147 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3147 Tue, 02 Jun 2009 10:51:00 +0000 VIENNA, June 2 /PRNewswire/ -- The media recently reported that Miss California entered the pageant with "fake breasts." This wouldn't have happened with silicon-free breast enlargement! This novel... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3146 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3146 Tue, 02 Jun 2009 09:00:00 +0000 SUNNYVALE, California, June 1 /PRNewswire/ -- Clinical trial results presented at the Digestive Disease Week in Chicago today reveal that endoscopic radiofrequency ablation performed in a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3144 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3144 Mon, 01 Jun 2009 23:00:00 +0000 LONDON, June 1 /PRNewswire/ -- A new survey, commissioned by Activia has revealed a bloated belly as the number one body complaint amongst British women[1] with 52% of women surveyed stating that... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3141 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3141 Mon, 01 Jun 2009 16:00:00 +0000 GATESHEAD, England, June 1 /PRNewswire/ -- A leading GP has welcomed the launch of a potentially revolutionary heart disease treatment that offers people around the world the hope of combating the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3138 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3138 Mon, 01 Jun 2009 11:54:00 +0000 GENEVA, May 30 /PRNewswire/ -- G-20 leaders pledged to provide the International Monetary Fund with $500 billion to help struggling economies, sparking global controversy. Yet startling research... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3133 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3133 Sat, 30 May 2009 21:00:00 +0000 MADRID, May 30 /PRNewswire/ -- The Spanish Head and Neck Cancer Cooperative Group (TTCC) announced today that Induction Chemotherapy (IC) delivered prior to standard ChemoRadiotherapy (CRT), a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3132 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3132 Sat, 30 May 2009 13:39:00 +0000 MANCHESTER, May 29 /PRNewswire/ -- Having to pay and display whilst visiting loved ones in hospital is life's biggest injustice payment according to new research released by The Co-operative ISA's. ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3131 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3131 Fri, 29 May 2009 17:36:00 +0000 COLLEGEVILLE, Pennsylvania, May 29 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced preliminary data from two ongoing studies, one evaluating neratinib... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3130 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3130 Fri, 29 May 2009 13:00:00 +0000 LONDON, May 27 /PRNewswire/ -- Merck Sharp & Dohme Limited (MSD) welcomes the publication of the guideline for type 2 diabetes newer agents1 from the National Institute for Health and Clinical... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3118 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3118 Wed, 27 May 2009 14:04:00 +0000 LONDON, May 27 /PRNewswire/ -- The incidence of cardiovascular disease is rising due to factors such as ageing, obesity, smoking and other cardiac ailments. Each year cardiovascular diseases cause... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3115 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3115 Wed, 27 May 2009 11:00:00 +0000 LONDON, May 27 /PRNewswire/ -- As many as 700,000 people in the UK suffer from a heart abnormality called arrhythmia, a potentially fatal condition, which the majority of Londoners have never heard... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3114 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3114 Wed, 27 May 2009 10:44:00 +0000 LONDON, May 26 /PRNewswire/ -- The European prebiotics market is diversifying and expanding in both importance and value throughout the food and beverage industry, with several exciting developments... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3105 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3105 Tue, 26 May 2009 11:00:00 +0000 MILAN, May 25 /PRNewswire/ -- Data presented from large-scale observational studies provide new insights into the day-to-day management of two major complications of CKD: anaemia and secondary... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3098 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3098 Mon, 25 May 2009 11:00:00 +0000 HUNTINGTON BEACH, California and AMSTERDAM, May 21 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced that leading researchers from Agendia, the University of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3095 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3095 Thu, 21 May 2009 13:27:00 +0000 PRAGUE, May 21 /PRNewswire/ -- Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3093 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3093 Thu, 21 May 2009 12:00:00 +0000 INDIANAPOLIS, May 21 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced it will begin enrolling patients this month in two separate but identical Phase III clinical trials of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3094 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3094 Thu, 21 May 2009 12:00:00 +0000 BASEL, Switzerland, May 21 /PRNewswire/ -- **This press release is not intended for the UK media** http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3089 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3089 Thu, 21 May 2009 06:00:00 +0000 LONDON, May 20 /PRNewswire/ -- A survey among Britain's 40,000 sufferers from dystonia - a serious neurological movement disorder causing painful muscle spasms - has shown a widespread ignorance... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3086 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3086 Wed, 20 May 2009 11:38:00 +0000 HELSINKI, May 20 /PRNewswire/ -- Researchers with ConvaTec Wound Therapeutics presented a series of in vitro studies demonstrating the advanced features and fluid handling capacity of the company's... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3084 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3084 Wed, 20 May 2009 09:30:00 +0000 LONDON, May 20 /PRNewswire/ -- We all know that women buy more lipstick in an economic downturn. But research undertaken by Oral-B to mark the launch of National Smile Month[1] today reveals the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3083 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3083 Wed, 20 May 2009 09:00:00 +0000 LONDON, May 19 /PRNewswire/ -- Regulatory processes differ across continents, posing challenges to drug launches. There is a pressing need to integrate the regulatory environment of the European... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3076 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3076 Tue, 19 May 2009 11:30:00 +0000 BRUSSELS, May 19 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3075 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3075 Tue, 19 May 2009 10:45:00 +0000 LONDON, May 19 /PRNewswire/ -- To view a Vodcast of Professor Peyman Hadji presenting the data click the following link: http://62.193.238.61/blueprinttv/expert/Expert-Opinion.html To view a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3070 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3070 Tue, 19 May 2009 00:01:00 +0000 LONDON, May 19 /PRNewswire/ -- To view a Vodcast of Professor Peyman Hadji presenting the data click here: http://62.193.238.61/blueprinttv/expert/Expert-Opinion.html To view a Vodcast of a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3071 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3071 Tue, 19 May 2009 00:01:00 +0000 LONDON, May 18 /PRNewswire/ -- The majority of post-menopausal women are uncomfortable talking about vaginal dryness and pain and are reluctant to seek medical help, according to results from a new... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3066 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3066 Mon, 18 May 2009 14:57:00 +0000 LONDON, May 18 /PRNewswire/ -- The advanced wound management market in Europe is experiencing high growth due to the heightened need for better and more cost-effective treatment. As a result, the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3062 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3062 Mon, 18 May 2009 11:00:00 +0000 PARIS, May 18 /PRNewswire/ -- The Institut Pasteur and M http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3059 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3059 Mon, 18 May 2009 07:00:00 +0000 LONDON, May 18 /PRNewswire/ -- The MS Society has today (18 May) called on Gordon Brown to ring-fence funds for stem cell research into multiple sclerosis (MS). Four years ago the UK Government... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3057 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3057 Mon, 18 May 2009 00:01:00 +0000 LONDON, May 15 /PRNewswire/ -- Tourist figures are returning to normal following the swine flu outbreak in Mexico, according to major carrier DialAFlight. Despite continued warnings from the press,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3054 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3054 Fri, 15 May 2009 13:29:00 +0000 MUNICH, May 15 /PRNewswire/ -- The SHARE steering committee announce the launch of Supporting Hypertension Awareness & Research Europe-wide (SHARE) program on World Hypertension Day 2009 (17th... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3053 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3053 Fri, 15 May 2009 09:00:00 +0000 LONDON, May 14 /PRNewswire/ -- Pre-hospital emergency care in the form of ambulances is one of the key factors improving the quality of healthcare across Europe. As emergency cases are on the rise... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3049 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3049 Thu, 14 May 2009 11:30:00 +0000 BRUSSELS, May 14 /PRNewswire/ -- On the 16th May Member of European Parliament Magor Imre Csibi (Romanian MEP of the Alliance for Liberals and Democrats), the UK National Obesity Forum (NOF) and the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3048 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3048 Thu, 14 May 2009 09:45:00 +0000 LUDWIGSHAFEN, Germany, May 13 /PRNewswire/ -- The very first thing many people do when they stumble out of bed in the morning is pour themselves a cup of coffee. The substance in the hot brew that... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3044 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3044 Wed, 13 May 2009 11:38:00 +0000 LONDON, May 11 /PRNewswire/ -- Empty offices and deserted restaurants are a real possibility if the Swine Flu virus successfully mutates, warns the Economist Intelligence Unit. The public has been... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3035 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3035 Mon, 11 May 2009 11:47:00 +0000 LONDON, May 11 /PRNewswire/ -- The turbulent pharmaceutical industry is demanding cheaper and innovative customer relationship management (CRM) solutions that will enable greater flexibility. CRM... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3034 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3034 Mon, 11 May 2009 11:34:00 +0000 LONDON, May 11 /PRNewswire/ -- The nation appears to be stuck in a downward spiral of unhealthy lifestyles as increasingly stressed Britons may be looking to save time and money by cutting back on... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3029 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3029 Mon, 11 May 2009 08:00:00 +0000 LONDON, May 6 /PRNewswire/ -- Analog screening systems are gradually being replaced by digital mammography systems. Screening programmes for breast cancer detection are responsible for driving the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3008 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3008 Wed, 06 May 2009 12:00:00 +0000 CAPE TOWN, South Africa, May 6 /PRNewswire/ -- The healthcare industry in South Africa faces substantial challenges, including vast inequalities in access to care. The public sector is responsible... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3005 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3005 Wed, 06 May 2009 09:00:00 +0000 LONDON, May 5 /PRNewswire/ -- Initiatives taken by European governments and healthcare authorities to install infection surveillance systems have aimed at improving efficiency levels and reducing... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3002 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3002 Tue, 05 May 2009 13:57:00 +0000 PLAN-LES-OUATES, Switzerland, May 5 /PRNewswire/ -- Viroblock SA announces that its antiviral products boosts the efficacy of facemasks by at least 99.0%, i.e. 100 times better and a peak performance... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3001 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3001 Tue, 05 May 2009 13:30:00 +0000 CAPE TOWN, South Africa, May 5 /PRNewswire/ -- Increased public and private expenditure on healthcare, coupled with increasing levels of medical insurance coverage and continued foreign donor funding... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2998 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2998 Tue, 05 May 2009 09:00:00 +0000 LONDON, May 4 /PRNewswire/ -- The Healthcare Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the Global Active Pharmaceutical Ingredients... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2993 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2993 Mon, 04 May 2009 10:30:00 +0000 SOUTHAMPTON, England, May 1 /PRNewswire/ -- People who want to take extra precautions against swine flu should look for masks with built-in filters, according to Dr Robin J Harman, a pharmaceutical... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2990 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2990 Fri, 01 May 2009 12:55:00 +0000 ANDOVER, England, April 30 /PRNewswire/ -- Almost 1 in 8 managers in the UK has a problem trusting their staff when it comes to taking time off to visit the dentist, research released today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2973 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2973 Wed, 29 Apr 2009 07:00:00 +0000 DUBLIN, April 28 /PRNewswire/ -- Emerging research presented today at a symposium during the Society for Research on Nicotine and Tobacco (SRNT) shows that optimizing therapeutic nicotine products... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2962 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2962 Tue, 28 Apr 2009 18:30:00 +0000 EDINBURGH, April 27 /PRNewswire/ -- Data from leading flight search company Skyscanner (http://www.Skyscanner.net) shows that travellers planning trips to Mexico have so far been undeterred by the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2954 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2954 Mon, 27 Apr 2009 17:49:00 +0000 LONDON, April 27 /PRNewswire/ -- The Healthcare Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the Pharmaceutical CRM Market to be held on... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2949 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2949 Mon, 27 Apr 2009 11:17:00 +0000 LONDON, April 27 /PRNewswire/ -- In 2008 biometric vendors witnessed massive growth; however the same downturn that affected banking, construction industry and retail stores since the end of 2008... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2948 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2948 Mon, 27 Apr 2009 09:00:00 +0000 COLUMBIA, Maryland, April 24 /PRNewswire/ -- Since it was cleared as an in vitro assessment of cell-mediated immunity in immunosuppressed patient populations, numerous clinical investigations have... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2945 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2945 Fri, 24 Apr 2009 14:45:00 +0000 LONDON, April 23 /PRNewswire/ -- Parents and caregivers concerned about the use of Bonjela and Bonjela Cool Mint Gel on children under the age of 16 should consult their pharmacist, the Royal... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2930 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2930 Wed, 22 Apr 2009 11:41:00 +0000 MELBOURNE, Australia, April 22 /PRNewswire/ -- Researchers in The Netherlands have achieved outstanding success in blocking the lifecycle of the mosquitoes which transmit malaria. The trials... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2925 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2925 Wed, 22 Apr 2009 07:00:00 +0000 LONDON, April 22 /PRNewswire/ -- The UK Advertising Standards Authority (ASA) today ruled that Pfizer's groundbreaking cinema advertising in which a man is seen coughing-up a dead rat did not breach... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2923 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2923 Tue, 21 Apr 2009 08:00:00 +0000 LONDON, April 21 /PRNewswire/ -- A widespread confusion and ignorance about multiple sclerosis (MS) in the minds of the general public has been revealed in a new survey. The results of the poll... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2915 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2915 Tue, 21 Apr 2009 07:46:00 +0000 MILAN, Italy, April 20 /PRNewswire/ -- The European Health Technology Institute for Socio-Economic Research (EHTI) today presents at a high level workshop at Bocconi University in Milan, Italy. The... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2912 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2912 Mon, 20 Apr 2009 16:36:00 +0000 PITTSBURGH, April 20 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds a 71.2% controlling interest, has been... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2910 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2910 Mon, 20 Apr 2009 15:20:00 +0000 SALZBURG, Austria, April 20 /PRNewswire/ -- Do children's house shoes fit properly? This question was the subject of a study conducted on pre-school and elementary school children by an... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2905 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2905 Mon, 20 Apr 2009 08:00:00 +0000 LONDON, April 20 /PRNewswire/ -- Bottled water body launches new campaign as research reveals that Britons are drinking almost 7bn extra calories by replacing bottled water with sugary drinks ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2904 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2904 Sun, 19 Apr 2009 12:00:00 +0000 BERLIN, Germany, April 16 /PRNewswire/ -- In response to the threat of global malnutrition and food insecurity, the recently established Humboldt Forum for Food and Agriculture has urged... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2895 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2895 Thu, 16 Apr 2009 14:00:00 +0000 ARNHEM, The Netherlands, April 16 /PRNewswire/ -- The European Association of Urology (EAU) has taken into consideration the recent scientific information on randomised screening studies on... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2891 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2891 Thu, 16 Apr 2009 12:07:00 +0000 CAPE TOWN, South Africa, April 16 /PRNewswire/ -- The pharmaceuticals market in Tanzania presents significant growth opportunities for local companies. Generic drug production is driving prices down,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2890 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2890 Thu, 16 Apr 2009 09:00:00 +0000 MILFORD, Massachusetts, April 16 /PRNewswire/ -- Waters Corporation (NYSE: WAT) and the University of Warwick, Coventry and Warwickshire, England, today signed a collaborative research agreement... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2888 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2888 Thu, 16 Apr 2009 07:00:00 +0000 LONDON, April 15 /PRNewswire/ -- Pharmacies across Great Britain should look out for new patient guidance on counterfeit medication and its dangers which will be delivered from May 2009. The two... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2885 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2885 Wed, 15 Apr 2009 18:01:00 +0000 LONDON, April 16 /PRNewswire/ -- The Royal Pharmaceutical Society of Great Britain is urging the public to be aware of the risks when purchasing medicines online, following a survey released by GP... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2886 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2886 Wed, 15 Apr 2009 13:20:00 +0000 UPPSALA, Sweden, April 14 /PRNewswire/ -- Oasmia Pharmaceutical, Uppsala, Sweden, has been granted Orphan Drug designation by the USA FDA of Paclical(R) for the treatment of ovarian cancer. Orphan... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2879 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2879 Tue, 14 Apr 2009 11:19:00 +0000 PALO ALTO, California, April 13 /PRNewswire/ -- Cell Biosciences, Inc., a provider of nanoproteomic analysis systems to life science researchers, today announced the publication of a landmark... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2877 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2877 Mon, 13 Apr 2009 14:00:00 +0000 NOVATO, California, April 13 /PRNewswire/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP) today announced the appointment of Patrice P. Rioux, M.D., Ph.D., as... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2876 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2876 Mon, 13 Apr 2009 11:30:00 +0000 LOMA LINDA, California, April 13 /PRNewswire/ -- Loma Linda University research just published in the American Journal of Clinical Nutrition compares the effects of walnuts and fatty fish in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2875 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2875 Mon, 13 Apr 2009 11:00:00 +0000 LONDON, April 9 /PRNewswire/ -- Think January is the biggest month for embarking upon a new diet and exercise regime? Think again. As it turns out, March is the most popular month for... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2867 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2867 Thu, 09 Apr 2009 08:00:00 +0000 GUETERSLOH, Germany, April 8 /PRNewswire/ -- Even in times of global challenges and growing transnational interdependencies - national governments still have considerable broad scope of action. This... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2865 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2865 Wed, 08 Apr 2009 14:42:00 +0000 NEW YORK, April 8 /PRNewswire/ -- Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced that U-Systems, Inc. selected Medidata Rave(R) as its... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2864 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2864 Wed, 08 Apr 2009 14:30:00 +0000 LONDON, April 8 /PRNewswire/ -- An attack by the National Secular Society (NSS) on the NHS chaplaincy service has been described as 'erroneous and simplistic' by Unite, the largest union in the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2862 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2862 Wed, 08 Apr 2009 11:39:00 +0000 LONDON, April 8 /PRNewswire/ -- UK patients are the first to benefit from the launch of a new heart drug prasugrel (Efient), following authorisation by the European Medicines Agency (EMEA). The... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2859 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2859 Wed, 08 Apr 2009 09:45:00 +0000 LONDON, April 8 /PRNewswire/ -- Nearly half of all hayfever sufferers are more irritable while they are suffering from hayfever symptoms, impacting on their relationships, according to a new survey... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2856 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2856 Tue, 07 Apr 2009 09:00:00 +0000 LONDON, April 6 /PRNewswire/ -- At least 20 million Europeans suffer from chronic, long-term sleep disorders every year and an additional ten million experience occasional sleeping problems. As a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2842 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2842 Mon, 06 Apr 2009 12:30:00 +0000 AMSTERDAM, April 6 /PRNewswire/ -- Twenty journals published by Elsevier (many on behalf of renowned societies) have been nominated for the Special Library Association's (SLA) Top 100 Journals in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2838 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2838 Mon, 06 Apr 2009 09:41:00 +0000 CAPE TOWN, South Africa, April 6 /PRNewswire/ -- Expanding therapeutic areas are creating significant opportunities for growth within the Kenyan pharmaceutical industry. Although infectious diseases... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2837 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2837 Mon, 06 Apr 2009 09:00:00 +0000 LONDON, April 2 /PRNewswire/ -- One specialist school nurse is looking after an estimated 6,900 children in England, according to Unite, the largest union in the country, which is calling for a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2834 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2834 Thu, 02 Apr 2009 15:25:00 +0000 CAPE TOWN, South Africa, April 2 /PRNewswire/ -- The global financial crisis, which had its origins in developed countries, is finally spreading to the developing corners of the world. Although... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2832 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2832 Thu, 02 Apr 2009 13:01:00 +0000 LONDON, April 2 /PRNewswire/ -- Adults aged 45 and over starting new sexual relationships are taking chances with their sexual health and are at risk of getting sexually transmitted infections,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2825 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2825 Thu, 02 Apr 2009 00:01:00 +0000 VENLO, Netherlands, April 1 /PRNewswire/ -- Results from an eight-year trial involving more than 130,000 women published today in The New England Journal of Medicine (NEJM) demonstrate that in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2824 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2824 Wed, 01 Apr 2009 22:00:00 +0000 GENEVA, Switzerland, March 31 /PRNewswire/ -- Viroblock SA has announced today that the first generation of VCCD Tech antiviral nasal spray formulation is active against human influenza. Viroblock's... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2814 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2814 Tue, 31 Mar 2009 15:00:00 +0000 LONDON, March 31 /PRNewswire/ -- Almost three decades after the discovery of HIV/AIDS, and despite big medical advances, there are still a significant number of HIV-infected persons who present late... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2809 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2809 Tue, 31 Mar 2009 08:00:00 +0000 ANDOVER, England, April 1 /PRNewswire/ -- An overwhelming majority (71%) of employers believe that companies are responsible for looking after the oral health of their employees. This is according to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2816 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2816 Tue, 31 Mar 2009 07:00:00 +0000 ANDOVER, England, April 1 /PRNewswire/ -- It has been revealed that a staggering 1 in 3 people in the UK are still struggling to find an NHS dentist, according to new research from Simplyhealth. ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2817 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2817 Tue, 31 Mar 2009 07:00:00 +0000 LONDON, March 30 /PRNewswire/ -- The health visiting crisis can still be measured in hours, according to Unite, the largest union in the country. The latest NHS workforce statistics, based on... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2805 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2805 Mon, 30 Mar 2009 16:35:00 +0000 TEL AVIV, Israel, March 30 /PRNewswire/ -- Anti-aging and skin renewal look to be one of the few industries not affected by the current economic downturn. The anti-aging skincare sales in the US... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2804 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2804 Mon, 30 Mar 2009 14:18:00 +0000 LONDON, March 30 /PRNewswire/ -- The higher incidence of chronic illnesses in Europe and the consequent increase of patient population in intensive care units has amplified the need for equipment... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2802 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2802 Mon, 30 Mar 2009 13:14:00 +0000 ORLANDO, Florida, March 28 /PRNewswire/ -- Percutaneous mitral valve repair using the MitraClip(R) system in symptomatic high-risk surgical patients with functional mitral regurgitation (FMR)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2798 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2798 Sat, 28 Mar 2009 19:00:00 +0000 HELSINKI, March 26 /PRNewswire/ -- The report entitled The Finnish Health Care System: A Value-Based Perspective highlights new strategic perspectives on the development needs of health care in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2785 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2785 Thu, 26 Mar 2009 10:00:00 +0000 LONDON, March 26 /PRNewswire/ -- A survey commissioned by the UK's leading dental payment plan specialist, Denplan, revealed that 89 per cent of us understand that poor dental health could impact on... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2783 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2783 Thu, 26 Mar 2009 08:00:00 +0000 LONDON, March 25 /PRNewswire/ -- Clinica - the world's leading medical technology journal - is calling for a public inquiry into the state of asbestos regulation in the UK, in light of discrepancies... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2779 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2779 Wed, 25 Mar 2009 13:12:00 +0000 LONDON, March 25 /PRNewswire/ -- Top medical experts, Professor Louis Appleby and Baroness Susan Greenfield, are backing a campaign about the health benefits of reading. A nationwide survey out... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2771 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2771 Wed, 25 Mar 2009 00:01:00 +0000 LONDON, March 24 /PRNewswire/ -- Counterfeit medicine is posing an increasing risk to the publics' health as the amount being sold online and through other sources grows internationally, according to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2769 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2769 Tue, 24 Mar 2009 18:21:00 +0000 PRINCETON, New Jersey, March 24 /PRNewswire/ -- In a survey conducted at the leading chemical exhibition in the United States -- InformexUSA -- visitors affiliated with the pharmaceutical outsourcing... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2764 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2764 Tue, 24 Mar 2009 14:00:00 +0000 PRINCETON, New Jersey, February 24 /PRNewswire/ -- In a survey conducted at the leading chemical exhibition in the United States -- InformexUSA -- visitors affiliated with the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2765 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2765 Tue, 24 Mar 2009 14:00:00 +0000 LONDON, March 24 /PRNewswire/ -- Two-thirds of UK doctors are opposed to the legalisation of euthanasia and physician-assisted suicide, according to research set to be published on Wednesday 25 March... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2761 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2761 Tue, 24 Mar 2009 12:12:00 +0000 DUBLIN, March 24 /PRNewswire/ -- A PopCap.co.uk pilot study that set out to assess if casual gaming could aid weight loss has revealed that casual gaming could be an effective tool in the fight... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2755 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2755 Tue, 24 Mar 2009 06:00:00 +0000 LONDON, March 23 /PRNewswire/ -- Medical images are increasingly becoming digitised. However, the exponential growth of digitised medical images poses an immense challenge in terms of management,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2749 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2749 Mon, 23 Mar 2009 10:54:00 +0000 ZURICH, Switzerland, March 20 /PRNewswire/ -- A new, innovative study shows that a single dose of palonosetron, the second generation 5-HT3 antagonist, plus dexamethasone not only... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2740 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2740 Fri, 20 Mar 2009 11:00:00 +0000 COPENHAGEN, March 20 /PRNewswire/ -- Lundbeck today announced the results of a new sleep survey of 6,694 Europeans (aged 18+) across seven countries to mark the second annual World Sleep Day, which... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2738 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2738 Fri, 20 Mar 2009 00:01:00 +0000 LONDON, March 18 /PRNewswire/ -- Despite the initial regulatory hiccups, the number of biosimilars in the European market is set to increase gradually. The patent expiry of key biopharmaceuticals has... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2726 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2726 Wed, 18 Mar 2009 13:14:00 +0000 LONDON, March 17 /PRNewswire/ -- While insulin syringes are the oldest delivery method available, they are currently experiencing a decline in use in Europe. Several factors have contributed to this... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2716 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2716 Tue, 17 Mar 2009 09:50:00 +0000 LONDON, March 16 /PRNewswire/ -- Millions of people already take a statin to lower their cholesterol and millions more are about to be prescribed these drugs under current guidelines. However, a new... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2711 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2711 Mon, 16 Mar 2009 09:00:00 +0000 MARSEILLE, France, March 16 /PRNewswire/ -- IPSOGEN SA (Alternext - FR0010626028 - ALIPS), a molecular diagnostic company specialized in the development, manufacturing and commercialization of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2710 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2710 Mon, 16 Mar 2009 07:30:00 +0000 CAPE TOWN, South Africa, March 11 /PRNewswire/ -- The medical insurance industry in key Sub-Saharan African countries such as Kenya, Tanzania, Ghana, Zambia, and Malawi is currently in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2695 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2695 Wed, 11 Mar 2009 08:00:00 +0000 PHILADELPHIA and LONDON, March 11 /PRNewswire/ -- The Healthcare and Science business of Thomson Reuters today released the white paper, "The Five Myths of Generic Competition," highlighting... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2694 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2694 Wed, 11 Mar 2009 04:01:00 +0000 EINDHOVEN, The Netherlands, March 10 /PRNewswire/ -- The Center for Translational Molecular Medicine (CTMM) - the Dutch public-private partnership committed to the research and development of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2692 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2692 Tue, 10 Mar 2009 16:22:00 +0000 STRASBOURG, France, March 10 /PRNewswire/ -- The European Kidney Health Alliance (EKHA) and World Kidney Day (WKD) organisations today call for action at EU level to support early... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2690 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2690 Tue, 10 Mar 2009 14:00:00 +0000 LONDON, March 11 /PRNewswire/ -- New research released to mark No Smoking Day (11 March) shows more than one in three (36%) of the nine million smokers in Great Britain are thinking about or planning... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2693 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2693 Tue, 10 Mar 2009 09:00:00 +0000 CAMBRIDGE, Massachusetts, March 10 /PRNewswire/ -- Tolerx, Inc., today announced that DEFEND (Durable Response Therapy Evaluation For Early or New Onset Type 1 Diabetes), the Phase 3 trial... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2685 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2685 Tue, 10 Mar 2009 08:00:00 +0000 LONDON, March 9 /PRNewswire/ -- Rising numbers of baby boomers with eye-ailments and soaring medical costs are causing European consumers to demand innovative diet supplements to protect their eyes... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2680 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2680 Mon, 09 Mar 2009 08:30:00 +0000 MUNICH, March 8 /PRNewswire/ -- For an expert opinion visit: http://62.193.238.61/blueprinttv/osteoporosis/IWDosteoporosis-expert-opinion.html The clocks will soon be changing, giving more... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2678 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2678 Sun, 08 Mar 2009 00:01:00 +0000 NAPA, California, March 5 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2672 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2672 Thu, 05 Mar 2009 14:25:00 +0000 LONDON, March 5 /PRNewswire/ -- The demand for a reliable, non-invasive, efficient and cost-effective technology that improves patients' lifestyles is boosting interest in bone growth and spinal... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2668 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2668 Thu, 05 Mar 2009 10:59:00 +0000 LONDON, March 4 /PRNewswire/ -- Britain's top component companies are refusing to spend less than a cost of a couple of pints of lager per employee for new research that could highlight the cancer... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2665 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2665 Wed, 04 Mar 2009 15:30:00 +0000 STOCKHOLM, March 4 /PRNewswire/ -- Diamyd Medical announces today that the Swedish Medical Products Agency has approved a study with the Diamyd(R) diabetes vaccine in children with high risk to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2664 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2664 Wed, 04 Mar 2009 15:12:00 +0000 LONDON, March 4 /PRNewswire/ -- Every hour and half in the UK a baby is stillborn or dies shortly after birth. That's 17 babies every day. There are strong indications that significant numbers of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2662 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2662 Wed, 04 Mar 2009 00:01:00 +0000 LONDON, March 2 /PRNewswire/ -- Providing low-cost, yet high quality products will be a key requirement that market participants will need to address in order to succeed in the eastern European high... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2645 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2645 Mon, 02 Mar 2009 12:29:00 +0000 MAIDENHEAD, England, March 2 /PRNewswire/ -- Wyeth announced today that its 7-valent pneumococcal conjugate vaccine, Prevenar(TM) (Pneumococcal saccharide conjugated vaccine, Adsorbed), has... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2641 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2641 Mon, 02 Mar 2009 07:12:00 +0000 MANCHESTER, England, March 2 /PRNewswire/ -- Epistem Plc (LSE:EHP) the UK biotechnology and research services company announced today that they have signed a research and development collaboration... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2640 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2640 Mon, 02 Mar 2009 07:00:00 +0000 LONDON, February 28 /PRNewswire/ -- Responding to guidance issued today by the Medicines and Healthcare products Regulatory Agency (MHRA), advising that cough and cold treatments should not be used... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2637 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2637 Sat, 28 Feb 2009 22:10:00 +0000 LONDON, February 26 /PRNewswire/ -- Mesothelioma is the least researched of the top twenty cancers, a disease which has devastated millions of families world wide; killing thousands each year in the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2630 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2630 Thu, 26 Feb 2009 17:00:00 +0000 LONDON, February 26 /PRNewswire/ -- Over 40 per cent of colon and breast cancer cases in some countries are preventable through healthy patterns of diet, physical activity and weight maintenance,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2624 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2624 Thu, 26 Feb 2009 10:00:00 +0000 LONDON, February 26 /PRNewswire/ -- The Healthcare industry's top performers will come together for Frost & Sullivan's 'Excellence in Healthcare Awards Banquet' on Thursday 19 March at ZSL London... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2625 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2625 Thu, 26 Feb 2009 10:00:00 +0000 ZURICH, Switzerland, February 26 /PRNewswire/ -- Recently, Solianis successfully finalized a series of tests during which patients with diabetes have worn its multisensor device for non-invasive... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2623 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2623 Thu, 26 Feb 2009 09:46:00 +0000 NEW YORK, February 26 /PRNewswire/ -- The South Central Strategic Health Authority (SHA) hired Bazian Ltd. to review fluoride safety concerns raised by a 2006 report of the US National Research... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2622 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2622 Thu, 26 Feb 2009 06:35:00 +0000 LONDON, February 25 /PRNewswire/ -- The patent expiry of blockbuster molecules has resulted in large pharmaceutical companies confronting intense competition from generics. CEOs have had to rethink... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2616 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2616 Wed, 25 Feb 2009 13:47:00 +0000 KVISTGAARD, Denmark, February 25 /PRNewswire/ -- Bavarian Nordic today announced that the first detailed data on PROSTVAC(TM) since the vaccine was licensed from the National Institutes of Health... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2613 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2613 Wed, 25 Feb 2009 10:59:00 +0000 LONDON, February 24 /PRNewswire/ -- Heptares Therapeutics Ltd, the drug discovery company focused on drugs targeting G-protein-coupled receptors (GPCRs), announces today it has raised GBP21 million... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2602 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2602 Tue, 24 Feb 2009 09:00:00 +0000 LEUVEN, Belgium and LUND, Sweden, February 23 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (OMXS: BINV) announce today that the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2593 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2593 Mon, 23 Feb 2009 07:00:00 +0000 HUNTINGTON BEACH, California, and AMSTERDAM, February 18 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced that a study demonstrating the direct predictive... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2573 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2573 Wed, 18 Feb 2009 13:44:00 +0000 CROSSWICKS, New Jersey, February 18 /PRNewswire/ -- The Myelodysplastic Syndromes (MDS) Foundation says data published in the peer reviewed medical journal The Lancet Oncology confirms VIDAZA... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2572 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2572 Wed, 18 Feb 2009 13:30:00 +0000 IRVINE, California, February 18 /PRNewswire/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced that in a newly... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2570 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2570 Wed, 18 Feb 2009 13:00:00 +0000 LYON, France, February 18 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT : SAN and NYSE : SNY), announced today that its investigational tetravalent dengue... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2568 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2568 Wed, 18 Feb 2009 08:00:00 +0000 PHILADELPHIA and LONDON, February 18 /PRNewswire/ -- The Healthcare and Science business of Thomson Reuters today released its 2009 Patent Focus Report. Authored by Joff Wild, editor of Intellectual... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2565 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2565 Wed, 18 Feb 2009 05:01:00 +0000 LONDON, February 17 /PRNewswire/ -- The Chemicals Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on Medical Trends Impacting the Chemicals and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2559 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2559 Tue, 17 Feb 2009 10:50:00 +0000 LONDON, February 17 /PRNewswire/ -- People in the UK are at risk of losing their sight as 44 percent know nothing about the country's leading cause of blindness,(1,2) Age-related Macular Degeneration... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2557 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2557 Mon, 16 Feb 2009 16:41:00 +0000 LONDON, February 16 /PRNewswire/ -- The Healthcare Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the European Cardiac Rhythm Management... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2555 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2555 Mon, 16 Feb 2009 11:37:00 +0000 DAR ES SALAAM, Tanzania, February 16 /PRNewswire/ -- Novartis and Medicines for Malaria Venture (MMV) announced today the African launch of Coartem(R) Dispersible. Coartem(R) Dispersible is... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2554 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2554 Mon, 16 Feb 2009 05:00:00 +0000 NAPA, California, February 12 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2547 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2547 Thu, 12 Feb 2009 14:25:00 +0000 LONDON, February 12 /PRNewswire/ -- New research released by the American Heart Association* reveals that Hibiscus Sabdariffa has a beneficial effect on reducing high blood pressure. "Daily... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2544 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2544 Thu, 12 Feb 2009 09:00:00 +0000 LONDON, February 11 /PRNewswire/ -- Pharmacists will gain access to a patient's Care Record for the first time under plans by NHS IT chiefs. Access has previously been limited to GPs. In a key... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2543 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2543 Wed, 11 Feb 2009 19:35:00 +0000 MUMBAI, India, February 11 /PRNewswire/ -- Since 2004, the Indian bakery industry has been making huge strides forward, undergoing a virtual metamorphosis thanks to increasing consumer gravitation... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2537 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2537 Wed, 11 Feb 2009 08:11:00 +0000 BUDAPEST, Hungary, LONDON and PRINCETON, New Jersey, February 10 /PRNewswire/ -- ThalesNano today announced a big step forward in the evolution of flow chemistry with the independent publication of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2536 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2536 Tue, 10 Feb 2009 12:00:00 +0000 LONDON, February 10 /PRNewswire/ -- Microdosing or Phase 0 clinical testing has been gaining acceptance and might become an imperative phase of the drug development process in the years to come.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2535 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2535 Tue, 10 Feb 2009 11:44:00 +0000 LONDON, February 10 /PRNewswire/ -- Around four million[2] ears are syringed each year in the UK, costing the NHS an estimated GBP11.7 million. Much of this money could be saved if people took steps... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2532 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2532 Tue, 10 Feb 2009 07:00:00 +0000 LONDON, February 9 /PRNewswire/ -- Although the impact of the economic downturn has been felt throughout all industrial sectors, many thought that its impact on Pharmaceutical industries would be... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2527 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2527 Mon, 09 Feb 2009 08:30:00 +0000 LONDON, February 5 /PRNewswire/ -- Scientists have found evidence that a direct interaction between vitamin D and a common genetic variant alters the risk of developing multiple sclerosis (MS). ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2524 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2524 Thu, 05 Feb 2009 22:00:00 +0000 GENEVA, February 4 /PRNewswire/ -- Today the International Union Against Cancer (UICC) is launching "I love my healthy active childhood," a campaign to raise awareness about the link between excess... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2518 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2518 Wed, 04 Feb 2009 10:15:00 +0000 CAMBRIDGE, England, February 3 /PRNewswire/ -- Cambridge Cognition Ltd, developers of a clinical diagnostic product that provides early warning of neurodegenerative conditions including Alzheimer's,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2514 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2514 Tue, 03 Feb 2009 12:40:00 +0000 LONDON, February 3 /PRNewswire/ -- Results of a new Pan-European survey announced today have uncovered alarming new information regarding the eating habits of people with Type 2 diabetes. More than a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2511 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2511 Tue, 03 Feb 2009 08:00:00 +0000 GENEVA, Switzerland, February 3 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and its partner Newron Pharmaceuticals SpA (SWX: NWRN) announced today that the first Phase... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2510 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2510 Tue, 03 Feb 2009 06:00:00 +0000 LAHTI, Finland, February 2 /PRNewswire/ -- The demand for medical devices has been increasing in recent years in Russia. Demand for imported high-tech medical devices is so high because local... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2506 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2506 Mon, 02 Feb 2009 11:48:00 +0000 LONDON, February 2 /PRNewswire/ -- The health visiting crisis has been further highlighted by new research revealing that more than 70% of GP practices are experiencing increased demands for... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2503 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2503 Mon, 02 Feb 2009 00:01:00 +0000 LONDON, January 30 /PRNewswire/ -- Yet life itself depends on salt, so why did a life giving substance became such a toxic force in the modern lifestyle? And why did one of the most complex minerals... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2502 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2502 Fri, 30 Jan 2009 17:48:00 +0000 SARDINIA, Italy, January 30 /PRNewswire/ -- Buying a Villa in Sardinia has always been a good investment, but now you might have more reason to invest in a property and spend time there. Legend has... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2501 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2501 Fri, 30 Jan 2009 17:39:00 +0000 INGELHEIM, Germany, January 30 /PRNewswire/ -- Based on key results from the European Cooperative Acute Stroke Study (ECASS 3), the European Stroke Organisation (ESO) now recommends that Actilyse(R)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2498 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2498 Fri, 30 Jan 2009 08:30:00 +0000 LONDON, January 30 /PRNewswire/ -- Ahead of the publication on Friday 30 January of a paper in The Lancet Neurology reporting the results of a trial involving stem cell transplantation in people with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2496 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2496 Thu, 29 Jan 2009 15:16:00 +0000 VIENNA, Austria, January 29 /PRNewswire/ -- The year 2008 marked the first time that ticks infected with the TBE virus were detected at more than 1,500 meters above sea level - one of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2495 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2495 Thu, 29 Jan 2009 14:59:00 +0000 AMSTERDAM, The Netherlands, January 28 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today during the Phacilitate Cell &... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2490 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2490 Wed, 28 Jan 2009 18:30:00 +0000 LONDON, January 27 /PRNewswire/ -- Cannibalisation, high market complexity and significant barriers to entry are all influencing the European tissue sealants and topical hemostats markets. However,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2477 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2477 Tue, 27 Jan 2009 12:16:00 +0000 MISSISSAUGA, Ontario, January 27 /PRNewswire/ -- "A 2005 Japan impotence study uses soft words about hard seats suggesting motorbike 'vibration may cause ED' and 'more studies are needed to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2475 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2475 Tue, 27 Jan 2009 10:07:00 +0000 MALVERN, Pennsylvania, January 26 /PRNewswire/ -- A pivotal clinical trial published in the January 2009 issue of the journal Gynecologic Oncology demonstrated the utility of combining... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2473 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2473 Mon, 26 Jan 2009 15:12:00 +0000 YOQNEAM, Israel, January 26 /PRNewswire/ -- UltraShape, a global leader in non-invasive fat reduction and body contouring, today announced the publication of extensive scientific and pre-clinical... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2466 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2466 Mon, 26 Jan 2009 09:00:00 +0000 CAMBRIDGE, England, January 26 /PRNewswire/ -- Mundipharma today announced that 13 countries* to date have received approval of Targin, a new combination therapy designed to control severe chronic... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2464 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2464 Mon, 26 Jan 2009 00:01:00 +0000 MAIDENHEAD, England, January 23 /PRNewswire/ -- The UK arm of the international Psoriasis Uncovered survey, which aims to reveal the true impact of psoriasis on patients' lives, is being... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2461 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2461 Fri, 23 Jan 2009 12:15:00 +0000 GENEVA, Switzerland, January 23 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that the CLARITY(1) Phase III pivotal trial of its proprietary oral... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2459 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2459 Fri, 23 Jan 2009 07:00:00 +0000 LONDON, January 22 /PRNewswire/ -- The availability of anti-obesity drug Orlistat from pharmacies provides accessible and convenient care for patients, said the Royal Pharmaceutical Society of Great... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2456 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2456 Thu, 22 Jan 2009 12:42:00 +0000 MUNICH, Germany, January 22 /PRNewswire/ -- Less than a third of patients in Europe achieve acceptable blood pressure control. The remaining two thirds are "challenging patients" i.e. patients whose... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2455 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2455 Thu, 22 Jan 2009 11:00:00 +0000 AMSTERDAM, January 22 /PRNewswire/ -- Elsevier, the world's leading publisher of scientific, medical and technical products and services, today announced the European availability of illumin8... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2453 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2453 Thu, 22 Jan 2009 09:08:00 +0000 NEW YORK, January 22 /PRNewswire/ -- Manhattan Research, a global healthcare and pharmaceutical market research company, today announced the release of Taking the Pulse(R) Europe v8.0, its European... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2451 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2451 Thu, 22 Jan 2009 08:00:00 +0000 PHILADELPHIA and LONDON, January 21 /PRNewswire/ -- Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, has announced the availability of three... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2447 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2447 Wed, 21 Jan 2009 15:39:00 +0000 HAYWARDS HEATH, England, January 21 /PRNewswire/ -- Cat owners are significantly less likely to suffer the physical and emotional symptoms of the 'winter blues', a new study has found. Findings... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2443 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2443 Wed, 21 Jan 2009 10:51:00 +0000 LONDON, January 21 /PRNewswire/ -- RPSGB is the professional and regulatory body for pharmacists in England, Scotland and Wales. It also regulates pharmacy technicians on a voluntary basis, which is... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2442 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2442 Tue, 20 Jan 2009 17:43:00 +0000 VIENNA, Austria, January 20 /PRNewswire/ -- Recently the media reported on the suicide of the famous businessman Merckle. However, this case is just the tragic culmination of the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2438 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2438 Tue, 20 Jan 2009 09:00:00 +0000 LONDON, January 19 /PRNewswire/ -- The Healthcare Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the European Medical Imaging Market to be... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2434 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2434 Mon, 19 Jan 2009 11:53:00 +0000 BERGISCH GLADBACH, Germany, January 16 /PRNewswire/ -- Miltenyi Biotec announces the worldwide release of the MACSQuant(TM) Analyzer, a novel and compact flow cytometer for multiparameter... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2425 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2425 Fri, 16 Jan 2009 08:00:00 +0000 LONDON, January 15 /PRNewswire/ -- A hard-hitting advert will hit cinema screens across the country this Friday (16 January) in a bid to warn people about the real risks of purchasing prescription... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2421 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2421 Thu, 15 Jan 2009 11:40:00 +0000 LONDON, January 15 /PRNewswire/ -- One in 10 Brits admits to feeling depressed every day, according to a new survey by Virgin Active, the UK's premier health club chain and research company Tick... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2419 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2419 Thu, 15 Jan 2009 07:00:00 +0000 LONDON, January 14 /PRNewswire/ -- Yes, it's true - UK children really do prefer the taste of oranges and strawberries over soft-drink flavours like fizzy cola. That's just one of the findings... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2412 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2412 Wed, 14 Jan 2009 15:32:00 +0000 NOTTINGHAM, England, January 14 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2410 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2410 Wed, 14 Jan 2009 12:53:00 +0000 LONDON, January 14 /PRNewswire/ -- The vaccines market, which was earlier associated with low profit margins and slow growth rates, has gained momentum in recent years through innovation. The... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2409 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2409 Wed, 14 Jan 2009 11:48:00 +0000 LONDON, January 13 /PRNewswire/ -- The European heart health ingredients market is developing lucratively due to the growth in the functional foods sector, triggered by a global fitness fad among... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2399 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2399 Tue, 13 Jan 2009 11:44:00 +0000 UPPSALA, Sweden, January 13 /PRNewswire/ -- Beactica AB, the Swedish fragment-based drug discovery company, today announced a new research collaboration agreement with GE Healthcare (Chalfont St.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2395 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2395 Tue, 13 Jan 2009 08:00:00 +0000 LEIDEN, The Netherlands, January 13 /PRNewswire/ -- ProFibrix B.V., today announced that it has concluded a commercial license agreement with Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange:... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2394 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2394 Tue, 13 Jan 2009 07:00:00 +0000 TORONTO, Canada, January 13 /PRNewswire/ -- Amorfix Life Sciences, a company focused on treatments and diagnostics for brain wasting diseases, today announced it has tested 10,000 blood donations... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2392 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2392 Tue, 13 Jan 2009 05:02:00 +0000 LONDON, January 12 /PRNewswire/ -- Planalytics Inc. announced today that Lloydspharmacy, a leading pharmacy chain with more than 1,700 stores in the UK, has licensed its Business Weather... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2391 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2391 Mon, 12 Jan 2009 17:09:00 +0000 PHILADELPHIA and LONDON, January 12 /PRNewswire/ -- Thomson Reuters today announced that it has published a new white paper on the topic of biomarkers drawing on expert insight from academics and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2388 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2388 Mon, 12 Jan 2009 13:00:00 +0000 LONDON, January 12 /PRNewswire/ -- The European telemetry equipment market is in a developmental stage and is dominated by a few large players. Growth rates are currently low but will rise... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2387 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2387 Mon, 12 Jan 2009 12:34:00 +0000 LEEDS, England, January 9 /PRNewswire/ -- MYA Cosmetic Surgery, one of the UK's leading cosmetic surgery providers, has reported a staggering 25% increase in enquiries compared to the same period... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2381 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2381 Fri, 09 Jan 2009 16:04:00 +0000 LONDON, January 8 /PRNewswire/ -- January 2009: New research commissioned by dental payment plan provider, Denplan, has revealed that the Tooth Fairy is likely to become known as a miser this year as... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2370 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2370 Thu, 08 Jan 2009 07:00:00 +0000 SAN DIEGO, January 6 /PRNewswire/ -- Amira Pharmaceuticals, Inc. announced AM211, Amira's internally discovered oral drug candidate for the treatment and control of inflammatory and allergic diseases... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2360 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2360 Tue, 06 Jan 2009 15:00:00 +0000 BOZEN, Italy, January 5 /PRNewswire/ -- Health Robotics today announced that the European Union (EU) Commission and eTen have made available the first results of the SafeChemo Project it sponsored at... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2354 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2354 Mon, 05 Jan 2009 14:00:00 +0000 CHICAGO, Illinois, December 31 /PRNewswire/ -- A landmark study published today in the New England Journal of Medicine (NEJM) demonstrates that use of a specially designed machine to store... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2351 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2351 Wed, 31 Dec 2008 22:00:00 +0000 GRONINGEN, The Netherlands, December 31 /PRNewswire/ -- Results from a landmark trial published today in the New England Journal of Medicine, show that in transplanted kidneys preserved... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2352 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2352 Wed, 31 Dec 2008 22:00:00 +0000 CAMBRIDGE, England, December 29 /PRNewswire/ -- Stem Cell Sciences plc (AIM:STEM, ASX:STC) is pleased to announce that pioneering research describing a technique for creating authentic embryonic stem... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2347 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2347 Mon, 29 Dec 2008 12:00:00 +0000 READING, England, December 23 /PRNewswire/ -- We all know how hard it is to avoid tasty treats such as chocolate and crisps but it is even more challenging over the festive season. According to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2344 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2344 Tue, 23 Dec 2008 11:00:00 +0000 REHOVOT, Israel; JERSEY CITY, New Jersey; PHILADELPHIA, December 22 /PRNewswire/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2341 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2341 Mon, 22 Dec 2008 13:00:00 +0000 TORONTO, December 19 /PRNewswire/ -- Amorfix Life Sciences, a company focused on treatments and diagnostics for brain wasting diseases, today announced it achieved 100% sensitivity and 100%... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2337 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2337 Fri, 19 Dec 2008 13:15:00 +0000 LONDON, December 19 /PRNewswire/ -- Britishcondoms.co.uk announces the VA w.o.w. Condom Feminine(R) is selling well and receiving excellent responses from women customers. The largest UK online... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2335 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2335 Fri, 19 Dec 2008 09:30:00 +0000 ANDOVER, Massachusetts, December 18 /PRNewswire/ -- Sentillion, the company that created healthcare single sign-on, today announced that KLAS, the healthcare industry's leading independent... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2330 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2330 Thu, 18 Dec 2008 18:54:00 +0000 LONDON, December 16 /PRNewswire/ -- An influential panel of dental stakeholders meeting in Westminster this week were unanimous in their view that the recession will significantly impact the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2309 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2309 Tue, 16 Dec 2008 08:00:00 +0000 LONDON, December 16 /PRNewswire/ -- Distension of the tummy can be reduced by up to 78% in people with Irritable Bowel Syndrome (IBS) simply by eating probiotic yogurt, according to a UK study... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2307 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2307 Mon, 15 Dec 2008 12:31:00 +0000 LONDON, December 15 /PRNewswire/ -- The immunoassay diagnostics market is in the late growth stage of the market lifecycle. It is being challenged by a number of factors including the commoditisation... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2303 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2303 Mon, 15 Dec 2008 11:26:00 +0000 HUNTINGTON BEACH, California and AMSTERDAM, December 13 /PRNewswire/ -- Dr. Michael Knauer from the Netherlands Cancer Institute today announced data uncovering a substantial group of traditionally... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2298 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2298 Sat, 13 Dec 2008 15:32:00 +0000 ZUG, Switzerland, December 12 /PRNewswire/ -- Swiss AmVac AG establishes comprehensive collaboration with the National Health Research Institutes in Taiwan to combat H5N1. H5N1/Influenza A is a flu... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2295 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2295 Fri, 12 Dec 2008 12:40:00 +0000 LONDON, December 12 /PRNewswire/ -- Weighing and measuring children when they enter and leave primary school is a waste of public money, as it is not tackling the obesity epidemic in England, Unite... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2294 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2294 Fri, 12 Dec 2008 11:57:00 +0000 FRIMLEY, England, December 11 /PRNewswire/ -- New data released today demonstrates that the addition of Zometa(R) (zoledronic acid) infusion to standard chemotherapy before breast cancer surgery... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2293 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2293 Thu, 11 Dec 2008 20:00:00 +0000 LONDON, December 11 /PRNewswire/ -- New long-term data from a major international breast cancer study reports that postmenopausal woman with hormone receptor-positive early-stage breast cancer who... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2291 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2291 Thu, 11 Dec 2008 15:46:00 +0000 LAUSANNE, Switzerland, December 10 /PRNewswire/ -- Diagnoplex, a developer of molecular cancer diagnostics today announced the closing of a Series A financing raising CHF10 million ($8.3 million).... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2282 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2282 Wed, 10 Dec 2008 06:56:00 +0000 WALTHAM, Massachusetts, December 8 /PRNewswire/ -- According to Millennium Research Group's (MRG's) European Markets for Urological Devices 2009 report, the prostate cancer device... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2266 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2266 Mon, 08 Dec 2008 08:07:00 +0000 HAMBURG, Germany, December 5 /PRNewswire/ -- Current methods of ultrasound transducer disinfection are in many cases not sufficient for clinical practice. This is the latest alarming result issued by... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2257 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2257 Fri, 05 Dec 2008 09:00:00 +0000 MENLO PARK, California, December 4 /PRNewswire/ -- Long-term data published in EuroIntervention showed that the expected decrease in Mitral Vale Area (MVA) after repair with the MitraClip(R)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2256 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2256 Thu, 04 Dec 2008 19:07:00 +0000 AMSTERDAM, December 4 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma announces today that it has successfully completed treatment of the last patient on its ATIR(TM) phase I/II clinical... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2254 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2254 Thu, 04 Dec 2008 15:07:00 +0000 BASEL, Switzerland, December 4 /PRNewswire/ -- Roche announced today that the European Commission has approved Pegasys(R) (peginterferon alfa-2a (40 KD)) plus Copegus(R) (ribavirin) for the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2253 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2253 Thu, 04 Dec 2008 14:40:00 +0000 GOTHENBURG, Sweden, December 3 /PRNewswire/ -- Cellectricon, a leading provider of screening solutions for drug discovery, today announced the signing of a collaborative agreement with The Automation... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2238 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2238 Wed, 03 Dec 2008 07:00:00 +0000 WASHINGTON, December 2 /PRNewswire/ -- Today Pascal Metrics Inc. publicly announces its offering of patient safety culture and risk management services for hospitals and healthcare systems. Serving... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2236 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2236 Tue, 02 Dec 2008 14:00:00 +0000 LONDON, December 2 /PRNewswire/ -- Services form an integral part of most of original equipment manufacturers' (OEMs') revenues. It has therefore become essential for service providers in the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2229 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2229 Tue, 02 Dec 2008 10:00:00 +0000 CAPE TOWN, South Africa, December 2 /PRNewswire/ -- The Healthcare group at Frost & Sullivan (http://www.healthcare.frost.com ) is pleased to announce that it will be hosting a free webinar on... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2228 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2228 Tue, 02 Dec 2008 08:48:00 +0000 LONDON, December 1 /PRNewswire/ -- As the economic downturn bites and food costs continue to rise, it's reassuring to know that there is no need to compromise the festive spirit on quality, taste,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2224 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2224 Mon, 01 Dec 2008 21:16:00 +0000 NAPA, California, December 1 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2223 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2223 Mon, 01 Dec 2008 21:05:00 +0000 GORLITZ, Germany, December 1 /PRNewswire/ -- German biotech company Partec is expanding its global leadership in specialized HIV monitoring and AIDS patient follow-up diagnostics for developing and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2220 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2220 Mon, 01 Dec 2008 09:30:00 +0000 KVISTGARD, Denmark, December 1 /PRNewswire/ -- Following a Request for Proposal issued in 2007 with the intent to procure an MVA-based, third generation smallpox vaccine, Public Works and Government... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2218 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2218 Mon, 01 Dec 2008 08:00:00 +0000 LONDON, December 1 /PRNewswire/ -- As the economic downturn bites and food costs continue to rise, it's reassuring to know that there is no need to compromise the festive spirit on quality, taste,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2216 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2216 Mon, 01 Dec 2008 06:00:00 +0000 ST ALBANS, England, November 28 /PRNewswire/ -- Psoriasis affects 2-3% of people in the UK and can create both physical and psychological distress. Psychological discomfort is made worse by the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2213 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2213 Fri, 28 Nov 2008 10:36:00 +0000 G http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2212 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2212 Fri, 28 Nov 2008 08:30:00 +0000 LONDON, November 26 /PRNewswire/ -- Ground breaking research by Bed-bugs.co.uk has brought new insight and previously unseen detail into the spread of bed bugs across London. By mapping bed bug... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2204 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2204 Wed, 26 Nov 2008 15:20:00 +0000 WORCESTER, England, November 26 /PRNewswire/ -- Ice, snow and bitter temperatures have already affected parts of the UK this Autumn and forecasters at Netweather.tv expect this to continue into... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2199 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2199 Wed, 26 Nov 2008 08:00:00 +0000 LONDON, November 26 /PRNewswire/ -- When broadcaster and health campaigner Anne Diamond reviewed some videogames earlier this year, her damnation was so scathing that it overshadowed The Byron... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2198 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2198 Wed, 26 Nov 2008 01:00:00 +0000 COLUMBUS, Ohio, November 25 /PRNewswire/ -- CAS REGISTRY, the world's most authoritative collection of disclosed chemical substance information, now includes 40 million organic and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2196 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2196 Tue, 25 Nov 2008 23:26:00 +0000 LONDON, November 24 /PRNewswire/ -- A study of people living with the devastating effects of multiple sclerosis (MS) has shown the true economic cost of living with the incurable, life-long... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2192 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2192 Mon, 24 Nov 2008 15:08:00 +0000 LONDON, November 24 /PRNewswire/ -- The European autoimmune disease diagnostics market has demonstrated sustained growth due to advances in detection technology and automation. Active consolidation... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2188 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2188 Mon, 24 Nov 2008 10:00:00 +0000 BEERSE, Belgium, November 21 /PRNewswire/ -- Janssen-Cilag announced today that ustekinumab, the first in a new class of biologics, has received a positive opinion for the treatment of moderate to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2187 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2187 Fri, 21 Nov 2008 11:51:00 +0000 SAN DIEGO, November 21 /PRNewswire/ -- Gen-Probe's (Nasdaq: GPRO) CE-marked APTIMA(R) HPV assay may be an important new molecular tool to more accurately detect high-risk human papillomavirus (HPV)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2180 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2180 Fri, 21 Nov 2008 08:00:00 +0000 LONDON and AMSTERDAM, November 20 /PRNewswire/ -- Concateno plc, Europe's largest provider of drug and alcohol testing programmes, and Royal Philips Electronics (NYSE:PHG, AEX:PHI) have today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2176 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2176 Thu, 20 Nov 2008 14:54:00 +0000 CORK, Ireland, November 20 /PRNewswire/ -- Tibotec BVBA today announced that it has begun enrolling patients in its phase III study of telaprevir (VX-950), an investigational protease inhibitor (PI),... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2170 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2170 Thu, 20 Nov 2008 08:30:00 +0000 LONDON, November 20 /PRNewswire/ -- New research commissioned by dental payment plan provider, Denplan, has revealed that we prioritise the health of our pets above our own healthcare. The... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2167 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2167 Thu, 20 Nov 2008 07:00:00 +0000 BASEL, Switzerland, November 20 /PRNewswire/ -- Switching dialysis patients to once-monthly Mircera(R) from older, more frequently dosed erythropoiesis stimulating agents (ESAs) could reduce... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2166 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2166 Thu, 20 Nov 2008 06:30:00 +0000 LONDON, November 19 /PRNewswire/ -- The real test of the Pharmaceutical Price Regulation Scheme (PPRS) agreement announced by the Department of Health today will be whether it delivers improved... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2165 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2165 Wed, 19 Nov 2008 17:17:00 +0000 LONDON, November 19 /PRNewswire/ -- With issues around patient comfort gaining momentum, hospitals and healthcare decision makers are recognising the need to consider patients' relief and welfare.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2160 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2160 Wed, 19 Nov 2008 10:00:00 +0000 JAMAICA PLAIN, Massachusetts, November 17 /PRNewswire/ -- Paloma Pharmaceuticals, Inc. today announced the publication of a first and seminal paper describing the Company's TOR complex inhibitor... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2146 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2146 Mon, 17 Nov 2008 14:00:00 +0000 BERLIN, November 17 /PRNewswire/ -- The German government's active support of biotechnology investments is one of the country's leading advantages to international investors. The German government's... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2143 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2143 Mon, 17 Nov 2008 09:30:00 +0000 WALTHAM, Massachusetts, November 17 /PRNewswire/ -- According to Millennium Research Group's (MRG's) Europe II Markets for Peripheral Vascular Devices report, covering Spain, Switzerland, Benelux,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2140 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2140 Mon, 17 Nov 2008 08:07:00 +0000 ROME, November 17 /PRNewswire/ -- World COPD Day 2008 features new patient and health professional initiatives that address the misconceptions and lack of awareness surrounding chronic obstructive... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2139 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2139 Mon, 17 Nov 2008 08:00:00 +0000 INGELHEIM, Germany, November 17 /PRNewswire/ -- Boehringer Ingelheim has marked a new milestone within its rapidly expanding oncology portfolio with the announcement today that the company has... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2137 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2137 Mon, 17 Nov 2008 07:00:00 +0000 CAMBRIDGE, England, November 14 /PRNewswire/ -- IRES Patent Upheld in Appeal Hearing at the EPO Stem Cell Sciences plc (AIM:STEM, ASX:STC) announces that European patent no. 0695361 covering its... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2131 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2131 Fri, 14 Nov 2008 12:00:00 +0000 LONDON, November 13 /PRNewswire/ -- Diabetic Hypoglycaemia (http://www.hypodiab.com), the influential online diabetes journal published by ESP Bioscience, supports the message of World Diabetes Day... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2128 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2128 Thu, 13 Nov 2008 17:08:00 +0000 GIBRALTAR, November 13 /PRNewswire/ -- Over a year into the smoking ban in the UK and more than 53 land based bingo halls have closed, bringing the number of clubs still open to about 550. Yes, the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2125 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2125 Thu, 13 Nov 2008 12:36:00 +0000 BRUSSELS, November 13 /PRNewswire/ -- November 14 is the most important day of the year for the over 250 million people with diabetes worldwide. World Diabetes Day draws attention to the global... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2120 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2120 Thu, 13 Nov 2008 00:01:00 +0000 CLEVELAND, Ohio and LOD, Israel, November 12 /PRNewswire/ -- Surgeons at the University of Rochester Medical Center, NY indicated that patient-specific CTA data can be converted to an endovascular... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2114 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2114 Wed, 12 Nov 2008 14:57:00 +0000 LONDON, November 13 /PRNewswire/ -- New research from the Royal Pharmaceutical Society of Great Britain (RPSGB) could shed light on the reasons behind the poor state of men's health in Britain. ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2119 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2119 Wed, 12 Nov 2008 11:31:00 +0000 PARIS, November 12 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that Russia has chosen inactivated polio vaccine (IPV) from Sanofi Pasteur for... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2110 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2110 Wed, 12 Nov 2008 09:30:00 +0000 NICE, France, November 12 /PRNewswire/ -- New survey results announced today, reveal a significant lack of information and education about the prevention, treatment and consequences of cervical... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2106 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2106 Wed, 12 Nov 2008 08:00:00 +0000 LONDON, November 12 /PRNewswire/ -- With banks downsizing, people losing their jobs, the housing market at a virtual standstill and the rising cost of living, it cannot have escaped your notice that... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2105 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2105 Wed, 12 Nov 2008 07:00:00 +0000 NEW YORK, November 10 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on The Medical House PLC (LSE: MLH.L), based... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2085 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2085 Mon, 10 Nov 2008 13:00:00 +0000 WELWYN GARDEN CITY, England, November 10 /PRNewswire/ -- In England alone, an estimated seven million people have NHS operations every year(1) and the majority of these are conducted under... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2079 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2079 Mon, 10 Nov 2008 09:00:00 +0000 OSLO and FOSTER CITY, California, November 10 /PRNewswire/ -- DiaGenic ASA (OSL: DIAG) and Applied Biosystems Inc. (NYSE: ABI) today announced the launch of BCtect(TM), a blood-based test for early... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2075 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2075 Mon, 10 Nov 2008 07:00:00 +0000 BASEL, Switzerland, November 10 /PRNewswire/ -- Interim study results from 90 renal centres in Germany confirm for the first time that in a real-life setting Mircera(R) maintains haemoglobin... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2074 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2074 Mon, 10 Nov 2008 06:30:00 +0000 NEW ORLEANS and LOS ANGELES, November 10 /PRNewswire/ -- Internationally recognized specialists from North America, Europe, Asia and Japan have come together today to launch the Residual Risk... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2073 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2073 Mon, 10 Nov 2008 02:00:00 +0000 TOKYO, November 7 /PRNewswire/ -- A significant portion of patients with atherothrombosis also have atrial fibrillation (AF), greatly increasing their risk for cardiovascular death, heart attack and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2070 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2070 Fri, 07 Nov 2008 15:57:00 +0000 HONG KONG, November 7 /PRNewswire/ -- An interim analysis of 12-month patient subset data from e-HEALING, a global post-marketing surveillance registry of OrbusNeich's Genous Bio-engineered R stent,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2068 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2068 Fri, 07 Nov 2008 13:00:00 +0000 LONDON, November 6 /PRNewswire/ -- New research published by the UK's largest trade union, Unite, shows investigation levels into major injuries to workers have declined by 43% between 2001/2 and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2059 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2059 Thu, 06 Nov 2008 10:32:00 +0000 CALGARY, Canada, November 4 /PRNewswire/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that it has made a decision to pursue a pivotal (Phase II/III) randomized... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2050 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2050 Tue, 04 Nov 2008 15:00:00 +0000 BASEL, Switzerland, November 1 /PRNewswire/ -- Cure rates for certain groups of difficult-to-treat hepatitis C patients can be improved significantly by extending the treatment period with PEGASYS(R)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2032 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2032 Sat, 01 Nov 2008 12:00:00 +0000 INGELHEIM, Germany, October 31 /PRNewswire/ -- Results from the PRESIDE*(1) survey, the largest study assessing the prevalence of female sexual problems, show that low sexual desire is the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2028 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2028 Fri, 31 Oct 2008 13:05:00 +0000 AMSTERDAM, The Netherlands, October 31 /PRNewswire/ -- Though condom prices are decreasing rapidly all over the world, prostitutes and other women working in the sex industry still have to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2027 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2027 Fri, 31 Oct 2008 08:15:00 +0000 BILTHOVEN and AMSTERDAM, The Netherlands, October 30 /PRNewswire/ -- InteRNA Technologies B.V. and VU university medical center in Amsterdam, VUmc, announce today the signing of a framework research... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2021 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2021 Thu, 30 Oct 2008 07:30:00 +0000 HELSINKI, October 28 /PRNewswire/ -- Northern Antibiotics Ltd., the developer of novel polymyxin derivatives for the treatment of infections caused by multidrug-resistant Gram-negative bacteria,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2003 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2003 Tue, 28 Oct 2008 16:30:00 +0000 ARNHEM, The Netherlands, October 28 /PRNewswire/ -- The number of prostate cancer cases is increasing rapidly. Fortunately not all these tumours need to be operated - some are slow growing... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1996 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1996 Tue, 28 Oct 2008 08:00:00 +0000 WASHINGTON, October 27 /PRNewswire/ -- Data from a pivotal trial and three other Phase 3 studies presented today indicate that Wyeth's (NYSE: WYE) investigational 13-valent pneumococcal conjugate... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1991 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1991 Mon, 27 Oct 2008 15:46:00 +0000 MAIDENHEAD, England, October 27 /PRNewswire/ -- New safety and efficacy data for active ankylosing spondylitis (AS) patients treated with ENBREL(R) (etanercept) were presented at the American... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1985 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1985 Mon, 27 Oct 2008 07:00:00 +0000 PARIS, October 23 /PRNewswire/ -- Sanofi-aventis announced today that the European Medicines Agency (EMEA) has recommended to the European Commission (EC) the temporary suspension of the marketing... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1975 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1975 Thu, 23 Oct 2008 17:18:00 +0000 VIENNA, Austria, October 22 /PRNewswire/ -- New data presented at the United European Gastroenterology Week (UEGW) confirm the efficacy and safety of prucalopride, a novel enterokinetic compound, in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1963 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1963 Wed, 22 Oct 2008 12:00:00 +0000 LONDON, October 22 /PRNewswire/ -- Diabetic Hypoglycaemia (http://www.hypodiab.com), the influential online diabetes journal published by ESP Bioscience, leads its new issue with a topical editorial,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1961 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1961 Wed, 22 Oct 2008 11:22:00 +0000 LONDON, October 22 /PRNewswire/ -- The MS Society has responded to today's embargoed announcement from the University of Cambridge relating to the alemtuzumab MS study results. The study has... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1966 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1966 Wed, 22 Oct 2008 10:05:00 +0000 LONDON, October 22 /PRNewswire/ -- The speech and language therapy service is 'heading towards crisis', a new survey of the profession by Unite, the largest union in the country, has revealed. ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1958 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1958 Wed, 22 Oct 2008 09:29:00 +0000 WALTHAM, Massachusetts, October 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that significant... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1956 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1956 Wed, 22 Oct 2008 08:00:00 +0000 LEEDS, England, October 22 /PRNewswire/ -- New research presented today shows that the information given to the volunteers of the disastrous Northwick Park "Elephant Man" trial would not have passed... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1953 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1953 Tue, 21 Oct 2008 19:00:00 +0000 VIENNA, Austria, October 21 /PRNewswire/ -- At the United European Gastroenterology Federation Annual Scientific Meeting in Vienna, Austria (UEGW Vienna 2008), world-renowned gastroenterologist... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1948 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1948 Tue, 21 Oct 2008 08:14:00 +0000 WALTHAM, Massachusetts, October 21 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1947 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1947 Tue, 21 Oct 2008 08:00:00 +0000 PARIS, October 20 /PRNewswire/ -- Providing a framework for Body Area Networks (BAN), defining a reliable communication protocol, optimizing BAN technologies and enhancing energy efficiency of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1933 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1933 Mon, 20 Oct 2008 08:00:00 +0000 PORTSMOUTH, England, October 20 /PRNewswire/ -- Down Syndrome Education International has been awarded a grant by the Big Lottery Fund to test a structured language and reading teaching programme... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1932 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1932 Mon, 20 Oct 2008 07:00:00 +0000 INGELHEIM and BIBERACH, Germany, October 17 /PRNewswire/ -- Boehringer Ingelheim announced that patients and physicians may have several innovative type 2 diabetes treatment alternatives available in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1928 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1928 Fri, 17 Oct 2008 11:30:00 +0000 LONDON, October 15 /PRNewswire/ -- The latest thinking on nursing's future is biased towards the acute sector, and not enough weight is given to community practitioners, Unite, the largest union in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1922 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1922 Wed, 15 Oct 2008 14:14:00 +0000 GENEVA, Switzerland, October 14 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) awarded a total of $2 million to five research teams to speed development of effective... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1911 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1911 Tue, 14 Oct 2008 09:00:00 +0000 ZURICH, Switzerland, October 13 /PRNewswire/ -- Solianis' multisensor system for non-invasive Continuous Glucose Monitoring is currently being tested by diabetic patients in the home and work... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1905 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1905 Mon, 13 Oct 2008 09:00:00 +0000 GENEVA, Switzerland, October 10 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that it has been named by Science magazine as a top employer in the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1895 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1895 Fri, 10 Oct 2008 06:00:00 +0000 AMSTERDAM, October 9 /PRNewswire/ -- For the first time in Europe a study is being conducted among men to gain information about the fit and feel of condoms. The American Center for Sexual Health... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1889 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1889 Thu, 09 Oct 2008 10:17:00 +0000 WALTON OAKS, England, October 9 /PRNewswire/ -- Today on World Sight Day leading experts aim to raise awareness of the eye disease glaucoma. It is estimated that there are currently up to 500,000... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1885 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1885 Wed, 08 Oct 2008 12:00:00 +0000 BILLERICA, Massachusetts, October 6 /PRNewswire/ -- Seahorse Bioscience today announced the release of the first ever analytical instrument for the kinetic measurement of mitochondrial... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1865 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1865 Mon, 06 Oct 2008 16:30:00 +0000 ANDOVER, England, October 6 /PRNewswire/ -- A major new health report unveiled today reveals that the credit crunch is leading to people being less likely to take time off sick. 83% of workers... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1856 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1856 Mon, 06 Oct 2008 00:01:00 +0000 LONDON, October 4 /PRNewswire/ -- The world's populations are ageing rapidly, bringing greater risk of blindness and vision impairment to millions. Around the world, organisations of many kinds are... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1855 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1855 Sat, 04 Oct 2008 22:19:00 +0000 STOCKHOLM, October 2 /PRNewswire/ -- Athera Biotechnologies AB and Dyax Corp. (NASDAQ:DYAX) announced today that they have entered into a collaboration to discover and to develop therapeutic products... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1845 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1845 Thu, 02 Oct 2008 12:30:00 +0000 BEERSE, Belgium, October 2 /PRNewswire/ -- Today, Janssen-Cilag are celebrating their 50 year commitment to researching and developing innovative medicines to help improve the lives of people with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1843 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1843 Thu, 02 Oct 2008 12:13:00 +0000 NEWBURY, England, October 2 /PRNewswire/ -- A new drug launched today could help in the fight against what experts and campaigners are calling a 'major patient safety issue'(1) - the prevention of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1842 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1842 Thu, 02 Oct 2008 11:35:00 +0000 WALTHAM, Massachusetts, September 29 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Shire's... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1818 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1818 Mon, 29 Sep 2008 08:00:00 +0000 PARIS, September 25 /PRNewswire/ -- Experts have predicted that by 2025, the number of people with diabetes will have increased by 20 per cent within Europe, 80 percent within Eastern Mediterranean... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1804 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1804 Thu, 25 Sep 2008 09:31:00 +0000 LONDON, September 25 /PRNewswire/ -- The Royal Pharmaceutical Society of Great Britain (RPSGB) has responded to the 2008 Which? report, A test of your own medicine. David Pruce, Director of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1801 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1801 Thu, 25 Sep 2008 00:01:00 +0000 BRUSSELS, Belgium, September 25 /PRNewswire/ -- The International Diabetes Federation announced today that it is calling on groups and individuals worldwide to get involved in activities to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1802 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1802 Thu, 25 Sep 2008 00:01:00 +0000 LEUVEN, Belgium, September 24 /PRNewswire/ -- Placebo-controlled, randomised, double-blind clinical trials provide the most comprehensive and strongest evidence of a drug's safety profile.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1799 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1799 Wed, 24 Sep 2008 16:10:00 +0000 COLLEGEVILLE, Pennsylvania, September 23 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced the initiation of the Community Acquired Pneumonia Immunization Trial... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1785 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1785 Tue, 23 Sep 2008 14:11:00 +0000 SEBASTIAN, Florida, September 23 /PRNewswire/ -- PHM International, Inc. a worldwide healthcare consultancy has published its report on investment and security risks due to the growing shortage... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1782 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1782 Tue, 23 Sep 2008 12:41:00 +0000 MAIDENHEAD, England, September 23 /PRNewswire/ -- Wyeth today announced study results from last week's 15th Paediatric Rheumatology European Congress (PRES) in London which highlight the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1779 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1779 Tue, 23 Sep 2008 10:37:00 +0000 LONDON, September 23 /PRNewswire/ -- Results of a recent survey reveal symptoms of vaginal discomfort are being ignored by women. Nearly 50% of women suffer from vaginal discomfort and yet around... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1778 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1778 Tue, 23 Sep 2008 08:00:00 +0000 WILMINGTON, Massachusetts, September 22 /PRNewswire/ -- Xenon Corp., a company internationally recognized as a leader and pioneer in the field of Pulsed Light systems, might have found the silver... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1769 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1769 Mon, 22 Sep 2008 05:00:00 +0000 GLOUCESTER, England, September 22 /PRNewswire/ -- The latest evidence for the unique joint-protection properties of a patented rose-hip powder - which is proving increasingly popular with sufferers... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1768 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1768 Mon, 22 Sep 2008 00:01:00 +0000 LONDON, September 19 /PRNewswire/ -- A new tool to help hospital doctors screen for Britain's most dangerous hospital killer is being rolled out across the country today and has the potential to save... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1762 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1762 Fri, 19 Sep 2008 11:51:00 +0000 INNSBRUCK, Austria, September 19 /PRNewswire/ -- Thirty seven medical experts in psychiatry from across the world have called on the medical community to take urgent action to optimize services for... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1760 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1760 Fri, 19 Sep 2008 09:00:00 +0000 GENEVA, Switzerland, September 18 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the initiation of a Phase III trial to evaluate the therapeutic... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1749 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1749 Thu, 18 Sep 2008 07:00:00 +0000 FRIMLEY, England, September 17 /PRNewswire/ -- New data continue to demonstrate the potential benefit of RAD001 (everolimus) for patients with advanced kidney cancer who have failed standard... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1745 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1745 Wed, 17 Sep 2008 13:50:00 +0000 NEW YORK, September 16 /PRNewswire/ -- Manhattan Research, a leading provider of access to physician and consumer opinions on the global healthcare market, reveals today the top pharmaceutical web... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1735 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1735 Tue, 16 Sep 2008 15:13:00 +0000 CALGARY, Canada, September 16 /PRNewswire/ -- SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1734 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1734 Tue, 16 Sep 2008 14:47:00 +0000 WALTHAM, Massachusetts, September 16 /PRNewswire/ -- According to Millennium Research Group's (MRG's) European Markets for Dental Implants 2008 report, the rising demand for... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1733 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1733 Tue, 16 Sep 2008 14:45:00 +0000 BRITISH COLUMBIA, Canada, September 16 /PRNewswire/ -- InNexus Biotechnology Inc. (TSX VENTURE: IXS; OTC Bulletin Board: IXSBF; http://www.ixsbio.com), a drug development company commercializing the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1732 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1732 Tue, 16 Sep 2008 14:32:00 +0000 NYON, Switzerland, September 16 /PRNewswire/ -- Mymetics Corporation (OTCBB: MYMX), a vaccine development company, is pleased to announce their preliminary SHIV challenge results on non-human... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1731 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1731 Tue, 16 Sep 2008 13:00:00 +0000 PORTSMOUTH, England, September 16 /PRNewswire/ -- A new analysis shows that many more babies are being born with Down syndrome today than 15 years ago in England, despite universally... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1729 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1729 Tue, 16 Sep 2008 11:00:00 +0000 WALTHAM, Massachusetts, September 16 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1726 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1726 Tue, 16 Sep 2008 08:00:00 +0000 BASEL, Switzerland, September 16 /PRNewswire/ -- Avastin (bevacizumab) remains the only biologic to provide overall survival (OS) benefit when used as first-line treatment in combination... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1724 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1724 Tue, 16 Sep 2008 07:30:00 +0000 NEW YORK, September 15 /PRNewswire/ -- Physician interest in live video detail from sales reps is growing, Manhattan Research, a leading provider of access to physician and consumer opinions on the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1722 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1722 Mon, 15 Sep 2008 15:29:00 +0000 BASEL, Switzerland, September 15 /PRNewswire/ -- The final analysis of the Avastin in lung study (AVAiL) in patients with advanced lung cancer has shown that not only did the drug significantly... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1721 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1721 Mon, 15 Sep 2008 14:25:00 +0000 WELLESLEY HILLS, Massachusetts, September 15 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee of the assets of Spherics, Inc. ("Spherics") for the benefit of creditors, announced today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1720 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1720 Mon, 15 Sep 2008 14:00:00 +0000 GENEVA, September 15 /PRNewswire/ -- New research published today at the annual meeting of the American Society for Bone and Mineral Research (ASBMR), Montr http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1717 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1717 Mon, 15 Sep 2008 09:30:00 +0000 WALTHAM, Massachusetts, September 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1715 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1715 Mon, 15 Sep 2008 08:00:00 +0000 KAKAMEGA, Kenya, September 15 /PRNewswire/ -- A new approach to fighting malaria, diarrhoeal diseases and HIV was launched today in the Western Kenyan district of Kakamega in Lurambi division. ... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1714 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1714 Mon, 15 Sep 2008 05:00:00 +0000 PARIS, September 10 /PRNewswire/ -- Sanofi-aventis, a world leader in diabetes care, announced results from two randomized clinical studies presented at the European Association for the Study of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1699 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1699 Wed, 10 Sep 2008 14:45:00 +0000 LONDON, September 10 /PRNewswire/ -- Manpower Software plc, the leading provider of workforce optimisation applications in the UK healthcare market, is pleased to announce during the company's first... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1692 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1692 Wed, 10 Sep 2008 07:00:00 +0000 LONDON, September 9 /PRNewswire/ -- The Work Foundation today announces changes to its structure and focus to consolidate its position as the leading research and consultancy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1688 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1688 Tue, 09 Sep 2008 16:36:00 +0000 ARNHEM, The Netherlands, September 9 /PRNewswire/ -- Every year 346,000 new cases of prostate cancer are detected in Europe, every day 240 men die of the condition. At least 1 in 10 people age 65... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1680 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1680 Tue, 09 Sep 2008 08:00:00 +0000 MANCHESTER, England, September 9 /PRNewswire/ -- Vaginal rings, similar to those used for contraception and hormone replacement therapy, could protect women from sexually-transmitted HIV, according... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1673 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1673 Tue, 09 Sep 2008 00:01:00 +0000 MANCHESTER, England, September 9 /PRNewswire/ -- The fight against fake medicines could soon be aided by a small, portable device that quickly measures the hardness of a tablet, revealing whether... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1674 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1674 Tue, 09 Sep 2008 00:01:00 +0000 MANCHESTER, England, September 9 /PRNewswire/ -- A new coating for urinary catheters could reduce the risk of infection, according to research presented at the British Pharmaceutical Conference (BPC)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1675 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1675 Tue, 09 Sep 2008 00:01:00 +0000 MANCHESTER, England, September 9 /PRNewswire/ -- Egg secretions from a worm that causes a deadly human disease may prove useful in gene therapy, according to research presented at the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1676 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1676 Tue, 09 Sep 2008 00:01:00 +0000 MANCHESTER, England, September 9 /PRNewswire/ -- Patients with chronic obstructive pulmonary disease (COPD) experience 55% fewer hospital admissions and 50% less visits to accident and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1677 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1677 Tue, 09 Sep 2008 00:01:00 +0000 ROME, September 8 /PRNewswire/ -- Results from two 24-week Phase III studies presented at the 44th European Association for the Study of Diabetes Annual Meeting demonstrate that saxagliptin, an... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1668 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1668 Mon, 08 Sep 2008 13:38:00 +0000 PARIS, September 8 /PRNewswire/ -- Sanofi-aventis, a world leader in diabetes care, announced the results of three non-interventional studies presented at the 44th annual meeting of the European... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1667 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1667 Mon, 08 Sep 2008 12:30:00 +0000 LAS VEGAS, September 8 /PRNewswire/ -- Ekahau Inc., a leading provider of Wi-Fi-based Real Time Location Systems (RTLS), at RFID World today introduced four new Wi-Fi tags that expand the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1665 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1665 Mon, 08 Sep 2008 10:00:00 +0000 LONDON, September 8 /PRNewswire/ -- Myconostica, a UK-based medical diagnostic company which specialises in rapid and highly specific tests for life-threatening fungal infections, today announces the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1662 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1662 Mon, 08 Sep 2008 07:00:00 +0000 LONDON, September 8 /PRNewswire/ -- Antibiotics are still being over-prescribed by GPs in contravention of guidelines, potentially contributing to antibiotic-resistant "superbugs", research launched... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1659 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1659 Mon, 08 Sep 2008 06:00:00 +0000 LONDON, September 8 /PRNewswire/ -- Over half the public are still ignorant about coronary heart disease (CHD) - the UK's leading killer disease, research launched at the British Pharmaceutical... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1660 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1660 Mon, 08 Sep 2008 06:00:00 +0000 LONDON, September 8 /PRNewswire/ -- A breakthrough method has been found to reduce the dangerous side-effects of a medicine that successfully tackles epilepsy, according to research released at the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1661 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1661 Mon, 08 Sep 2008 06:00:00 +0000 LONDON, September 8 /PRNewswire/ -- More than a third of patients with long-term fatigue conditions like Myalgic Encephalomyelitis (ME) believe complementary and alternative medicines (CAMs) are more... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1655 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1655 Mon, 08 Sep 2008 00:01:00 +0000 LONDON, September 8 /PRNewswire/ -- New treatment using a light-activated drug could revolutionise the fight against hospital "superbug", MRSA (otherwise known as meticillin resistant staphylococcus... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1656 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1656 Mon, 08 Sep 2008 00:01:00 +0000 LONDON, September 8 /PRNewswire/ -- An effective new method of diagnosing bowel (also known as colorectal, or large bowel) cancer using 'light' may soon be available, according to research presented... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1657 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1657 Mon, 08 Sep 2008 00:01:00 +0000 LONDON, September 8 /PRNewswire/ -- Pharmacists could help reduce GP workloads by 20 per cent, saving the NHS millions of pounds every year, according to Steve Churton, President of the Royal... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1658 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1658 Mon, 08 Sep 2008 00:01:00 +0000 LONDON, September 7 /PRNewswire/ -- Results from a new pooled data analysis presented at the European Headache and Migraine Trust International Congress (EHMTIC) 2008 today show that zolmitriptan... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1654 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1654 Sun, 07 Sep 2008 12:13:00 +0000 LONDON, September 7 /PRNewswire/ -- A third of patients have unnecessary tubes (cannulae) inserted when they are in hospital, needlessly exposing them to serious complications such as infection and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1652 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1652 Sun, 07 Sep 2008 06:00:00 +0000 LONDON, September 7 /PRNewswire/ -- The fight against fake medicines could soon be aided by a small, portable device that quickly measures the hardness of a tablet, revealing whether it is... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1653 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1653 Sun, 07 Sep 2008 06:00:00 +0000 LONDON, September 7 /PRNewswire/ -- One in four patients with diabetes are not receiving the appropriate cardiovascular medications, research launched at the British Pharmaceutical Conference (BPC)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1650 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1650 Sun, 07 Sep 2008 00:01:00 +0000 LONDON, September 7 /PRNewswire/ -- Research presented at the British Pharmaceutical Conference (BPC) in Manchester reveals that coating an artificial lens with antibiotics could significantly reduce... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1651 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1651 Sun, 07 Sep 2008 00:01:00 +0000 LONDON, September 6 /PRNewswire/ -- Basil can protect against the harmful effects of ageing, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester. Holy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1647 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1647 Sat, 06 Sep 2008 06:00:00 +0000 LONDON, September 6 /PRNewswire/ -- Almost 60% of women use at least one herbal product during pregnancy, research launched at the British Pharmaceutical Conference (BPC) in Manchester has... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1648 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1648 Sat, 06 Sep 2008 06:00:00 +0000 LONDON, September 5 /PRNewswire/ -- Most government and learning disability organisations are still failing to give the UK's 1.5 million people with learning disabilities (LD) a voice and a say in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1644 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1644 Fri, 05 Sep 2008 17:58:00 +0000 LUGANO, Switzerland, September 5 /PRNewswire/ -- The 33rd ESMO Congress in Stockholm, the premier European congress in Oncology, serves as a meeting place for medical oncologists, as well as a focal... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1640 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1640 Fri, 05 Sep 2008 10:00:00 +0000 LONDON, September 5 /PRNewswire/ -- Doctors need to pay special attention to people with migraine with aura as they could be at increased risk of stroke or heart attack, a London conference heard... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1641 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1641 Fri, 05 Sep 2008 10:00:00 +0000 GENEVA, September 4 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that it has entered into an agreement with Ablynx (Euronext Brussels: ABLX), to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1629 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1629 Thu, 04 Sep 2008 06:30:00 +0000 INGELHEIM, Germany, September 4 /PRNewswire/ -- Veterinarians and dog owners are today welcoming new research that delivers the promise of an extended happy life together for millions of dog owners... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1628 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1628 Thu, 04 Sep 2008 00:01:00 +0000 LONDON, September 4 /PRNewswire/ -- In the most recent Petplan Pet Census, an annual study of pet ownership in the UK, 97% of vets reported that a lack of funds had led to owners choosing euthanasia... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1626 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1626 Wed, 03 Sep 2008 18:21:00 +0000 LONDON, September 3 /PRNewswire/ -- The Fresh Prepared Salads Producer Group (FPSPG), which supplies washed and ready to eat salad packs to all the major UK supermarkets, supported by the CFA and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1625 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1625 Wed, 03 Sep 2008 17:58:00 +0000 MUNICH, Germany, September 3 /PRNewswire/ -- A sub-analysis of the TRITON-TIMI 38 clinical trial showed that treatment with prasugrel compared with clopidogrel significantly reduced the risk of new... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1618 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1618 Wed, 03 Sep 2008 08:16:00 +0000 CAMBRIDGE, England, September 2 /PRNewswire/ -- Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the commercialisation of stem cells and stem cell technologies, is pleased to announce... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1609 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1609 Tue, 02 Sep 2008 13:00:00 +0000 BURGESS HILL, England, September 1 /PRNewswire/ -- With some 20,000 UK children with Type 1 diabetes(i) about to start the new school year, new guidance from the National Institute for Health... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1599 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1599 Mon, 01 Sep 2008 00:01:00 +0000 BURGESS HILL, England, September 1 /PRNewswire/ -- With some 20,000 UK children with Type 1 diabetes(i) about to start the new school year, new guidance from the National Institute for Health... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1600 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1600 Mon, 01 Sep 2008 00:01:00 +0000 MUNICH, Germany, August 31 /PRNewswire/ -- Patients who were diabetic and diagnosed with acute coronary syndromes (ACS) were 40 percent less likely to suffer a heart attack if they were treated with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1598 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1598 Sun, 31 Aug 2008 14:31:00 +0000 UXBRIDGE, England, August 29 /PRNewswire/ -- NICE (National Institute for Health and Clinical Excellence) has published guidance that recommends Baraclude(R) (entecavir) as an option for treatment of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1594 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1594 Fri, 29 Aug 2008 11:02:00 +0000 STAINES, England, August 28 /PRNewswire/ -- Parents and paediatricians are today welcoming the results of new research that adds additional support for an effective and well tolerated treatment for... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1592 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1592 Thu, 28 Aug 2008 18:30:00 +0000 OSLO, August 28 /PRNewswire/ -- Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, today announced that the primary objective of its BC1-03 Phase II pain palliation study was met.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1589 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1589 Thu, 28 Aug 2008 10:22:00 +0000 FRIMLEY, England, August 27 /PRNewswire/ -- Novartis Pharmaceuticals UK Ltd (Novartis) today welcomed the Final National Institute for Health and Clinical Excellence (NICE) Technology Appraisal... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1571 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1571 Tue, 26 Aug 2008 16:52:00 +0000 COPENHAGEN, Denmark, August 25 /PRNewswire/ -- Genmab has announced plans to begin four studies of ofatumumab in chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Genmab A/S (OMX: GEN)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1557 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1557 Mon, 25 Aug 2008 08:40:00 +0000 TOKYO and INDIANAPOLIS, August 21 /PRNewswire/ -- A new, pre-specified analysis of the landmark Phase III head-to-head TRITON-TIMI 38 study showed patients who took prasugrel for acute... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1551 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1551 Thu, 21 Aug 2008 13:00:00 +0000 KVISTGARD, Denmark, August 19 /PRNewswire/ -- Today Bavarian Nordic published the company's interim report as of 30 June 2008. The full financial statements are available on the company's website.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1541 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1541 Tue, 19 Aug 2008 08:35:00 +0000 LONDON and PHILADELPHIA, August 18 /PRNewswire/ -- Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, has announced the availability of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1540 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1540 Mon, 18 Aug 2008 20:25:00 +0000 LONDON, August 18 /PRNewswire/ -- Misys plc (FTSE: MSY.L), the global application software and services company, today announces that CRDB Bank of Tanzania will implement Misys BankFusion Universal... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1539 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1539 Mon, 18 Aug 2008 09:33:00 +0000 EDMONTON, Canada, August 13 /PRNewswire/ -- BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Drug Safety... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1519 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1519 Wed, 13 Aug 2008 21:49:00 +0000 EDMONTON, Canada, August 13 /PRNewswire/ -- BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Drug Safety... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1533 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1533 Wed, 13 Aug 2008 21:49:00 +0000 MEXICO CITY, August 7 /PRNewswire/ -- Abbott (NYSE: ABT) presented pivotal data at the XVII International AIDS Conference (AIDS 2008) in Mexico City today showing that its investigational Norvir(R)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1502 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1502 Thu, 07 Aug 2008 23:33:00 +0000 BRITISH COLUMBIA, Canada, August 7 /PRNewswire/ -- InNexus Biotechnology Inc., (TSX: IXS.V; OTC Bulletin Board: IXSBF) (http://www.ixsbio.com), a drug development company commercializing the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1501 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1501 Thu, 07 Aug 2008 14:15:00 +0000 LONDON, August 6 /PRNewswire/ -- Half of UK physicians believe that the new five-yearly revalidation process for doctors will belittle their professionalism, and 65% fear it will reduce morale,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1495 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1495 Wed, 06 Aug 2008 16:14:00 +0000 BERLIN, August 6 /PRNewswire/ -- A 64-year-old man from France is the patient with the longest support time worldwide by the implantable heart support system INCOR(R). For five years already the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1494 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1494 Wed, 06 Aug 2008 12:57:00 +0000 HALIFAX, Canada, August 5 /PRNewswire/ -- ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, today announced receipt of patent approval from the Japanese Patent Office for its... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1486 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1486 Tue, 05 Aug 2008 14:00:00 +0000 REDWOOD CITY, California, August 4 /PRNewswire/ -- Video games are among the most popular entertainment media in the world. Now, groundbreaking research shows that a specially designed video game... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1479 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1479 Mon, 04 Aug 2008 13:00:00 +0000 LONDON, July 29 /PRNewswire/ -- A recent AHPMA survey among continence care professionals has painted a bleak picture on the current state of many continence services in the UK, largely due to lack... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1457 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1457 Tue, 29 Jul 2008 08:00:00 +0000 LUDWIGSHAFEN, Germany, July 23 /PRNewswire/ -- In campfire stories, you often hear that someone's hair turns grey or white overnight because of a stressful or frightening experience. That's pretty... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1437 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1437 Wed, 23 Jul 2008 11:39:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, July 22 /PRNewswire/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG) announces today that the first molecular test based on Rosetta Genomics' proprietary... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1434 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1434 Tue, 22 Jul 2008 13:30:00 +0000 OAK BROOK, Illinois and LONDON, July 22 /PRNewswire/ -- As they continue to increase their global presence, the world's pharmaceutical companies find themselves wrestling with a multitude... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1433 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1433 Tue, 22 Jul 2008 13:15:00 +0000 TORONTO, July 21 /PRNewswire/ -- Comprehensive Care International (CCI) and SHI Consulting Inc. (SHI) outlined their vision to create a sustainable operational advantage for hospitals worldwide.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1425 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1425 Mon, 21 Jul 2008 14:00:00 +0000 LONDON, July 21 /PRNewswire/ -- The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study at the Peninsula Medical School has reached an important milestone with the news that the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1424 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1424 Mon, 21 Jul 2008 13:20:00 +0000 SUNNYVALE, California, July 21 /PRNewswire/ -- BARRX Medical, Inc. today announced that 98.4 percent of patients having a precancerous condition of their esophagus called Barrett's esophagus... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1417 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1417 Mon, 21 Jul 2008 05:01:00 +0000 FRIMLEY, England, July 17 /PRNewswire/ -- UK workers are most likely to turn to alcohol, smoking and comfort eating to help them deal with the stress of their occupations, according to a new 'Stroke... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1409 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1409 Thu, 17 Jul 2008 08:00:00 +0000 PHILADELPHIA and LONDON, July 17 /PRNewswire/ -- The Scientific business of Thomson Reuters today announced the early findings of its 2008 Liquent Regulatory Affairs Trends Survey. The... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1405 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1405 Thu, 17 Jul 2008 05:01:00 +0000 WARSAW, Poland, July 14 /PRNewswire/ -- Preliminary findings from a landmark independent, academic study on the value of project management, released today at the Project Management Institute's... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1388 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1388 Mon, 14 Jul 2008 19:53:00 +0000 LONDON, July 14 /PRNewswire/ -- An online NHS Health Guide for people with diabetes has been launched on the national NHS website, NHS Choices http://www.nhs.uk The guide,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1387 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1387 Mon, 14 Jul 2008 12:24:00 +0000 AMSTERDAM, The Netherlands, July 14 /PRNewswire/ -- Elsevier, a leading publisher of scientific, technical and medical (STM) information, today announced that its online scientific research... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1386 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1386 Mon, 14 Jul 2008 12:00:00 +0000 STUTTGART, Germany, July 10 /PRNewswire/ -- The proportion of counterfeit products is reported recently from the European commission to be rapidly increasing. There are figures to back this up,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1375 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1375 Thu, 10 Jul 2008 08:00:00 +0000 COPENHAGEN, Denmark, July 9 /PRNewswire/ -- Summary: Genmab has completed recruitment of patients in the Phase II study of ofatumumab in combination with fludarabine and cyclophosphamide to treat... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1372 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1372 Wed, 09 Jul 2008 23:18:00 +0000 MAIDENHEAD, England, July 9 /PRNewswire/ -- The European Commission announced today a new 50 mg Enbrel(R) (etanercept) once weekly dosage regimen as an alternative to the currently approved 25 mg... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1364 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1364 Wed, 09 Jul 2008 10:00:00 +0000 MAIDENHEAD, England, July 8 /PRNewswire/ -- Wyeth applauds the countries of Cyprus, Hungary, the Kingdom of Bahrain, Republic of Ireland, Slovak Republic and Sweden for announcing their decisions to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1360 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1360 Tue, 08 Jul 2008 17:49:00 +0000 EGHAM, England, July 8 /PRNewswire/ -- Procter & Gamble Pharmaceuticals (P&GP) welcome the new Final Appraisal Determination (FAD) Guidance for the primary and secondary prevention of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1359 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1359 Tue, 08 Jul 2008 17:24:00 +0000 MAIDENHEAD, England, July 8 /PRNewswire/ -- Facts about drink driving - Nearly 1 in 5 convicted drink-drivers are caught the morning after drinking. http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1358 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1358 Tue, 08 Jul 2008 13:19:00 +0000 HONG KONG, July 7 /PRNewswire/ -- OrbusNeich today announced that data presented recently at the 17th Annual Meeting of the Japanese Society of Interventional Cardiology demonstrate that the Genous... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1354 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1354 Mon, 07 Jul 2008 15:41:00 +0000 BOSTON, Massachusetts, July 3 /PRNewswire/ -- The July 5 issue of the leading medical journal, The Lancet, highlights the Declaration of Istanbul on Organ Trafficking and Transplant Tourism,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1349 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1349 Thu, 03 Jul 2008 23:30:00 +0000 LONDON, July 3 /PRNewswire/ -- Britain's all-time favourite screen kiss has been revealed as Patrick Swayze kissing Demi Moore in the 1990 blockbuster film, Ghost. To celebrate the 13th annual... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1341 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1341 Thu, 03 Jul 2008 12:07:00 +0000 LONDON, July 2 /PRNewswire/ -- The European Alliance for Access to Safe Medicines (EAASM) has today unveiled its comprehensive research report - The Counterfeiting Superhighway. The report reveals... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1334 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1334 Wed, 02 Jul 2008 15:00:00 +0000 ROTTERDAM, Netherlands and DOYLESTOWN, Pennsylvania, July 1 /PRNewswire/ -- An interventional cardiology team led by Professor Patrick W. Serruys successfully placed a vProtect(TM) Luminal Shield in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1327 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1327 Tue, 01 Jul 2008 08:00:00 +0000 COPENHAGEN, June 30 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today it has reached a development milestone for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1324 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1324 Mon, 30 Jun 2008 18:27:00 +0000 LONDON, June 30 /PRNewswire/ -- On Monday 30 June, the final report of Lord Darzi's review of the NHS will be published and will talk of an NHS that "empowers patients" through care that is "high... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1322 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1322 Mon, 30 Jun 2008 15:30:00 +0000 LONDON, June 30 /PRNewswire/ -- Smokers wishing to quit would be wasting their money if they use complementary therapies such as hypnotherapy or acupuncture - smoking cessation experts claim today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1314 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1314 Mon, 30 Jun 2008 07:00:00 +0000 TALLINN, Estonia and COPENHAGEN, June 27 /PRNewswire/ -- Ministers of health from 53 countries (1), which make the WHO European Region, today signed a new charter on health systems, committing... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1310 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1310 Fri, 27 Jun 2008 13:11:00 +0000 AMSTERDAM, June 26 /PRNewswire/ -- Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced highlights of its Journal Impact Factor... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1303 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1303 Thu, 26 Jun 2008 12:22:00 +0000 LONDON, June 25 /PRNewswire/ -- The first cross-country report on the management and funding of colorectal cancer (CRC) reveals an urgent need for action to improve the survival of patients diagnosed... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1288 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1288 Wed, 25 Jun 2008 07:00:00 +0000 NEW YORK, June 24 /PRNewswire/ -- The Elsevier Foundation is seeking grant proposals for its Innovative Libraries in Developing Countries and New Scholars programs. Grant proposals for the two... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1279 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1279 Tue, 24 Jun 2008 17:30:00 +0000 PARIS, June 24 /PRNewswire/ -- The European Commission has granted marketing authorization for REYATAZ(R) (atazanavir sulfate 300mg once daily), administered with ritonavir 100 mg once daily and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1271 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1271 Tue, 24 Jun 2008 06:30:00 +0000 COPENHAGEN and TALLINN, June 23 /PRNewswire/ -- It has long been accepted that greater wealth allows people to make better health choices, but does the reverse apply? Does greater health lead to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1269 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1269 Mon, 23 Jun 2008 17:15:00 +0000 LOS ANGELES, June 23 /PRNewswire/ -- Canopus BioPharma, Inc. (OTC: CBIA), is pleased to announce that the South African Medicines Control Council has granted approval for a Phase II study in 30... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1264 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1264 Mon, 23 Jun 2008 13:00:00 +0000 KVISTGÅRD, Denmark, June 19 /PRNewswire/ -- Bavarian Nordic's cancer research unit, BN ImmunoTherapeutics, has completed an interim analysis of its first two clinical studies with MVA-BN(R)-HER2, a... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1247 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1247 Thu, 19 Jun 2008 08:17:00 +0000 ENFIELD, England, June 19 /PRNewswire/ -- To mark the launch of the Pet Health Information website ( http://www.pethealthinfo.org.uk), a nationwide search for 'it shouldn't happen to a pet' anecdotes... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1246 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1246 Thu, 19 Jun 2008 07:00:00 +0000 SAN DIEGO, California and CALGARY, Canada, June 18 /PRNewswire/ -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) announced today that it has completed the planned exploratory efficacy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1244 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1244 Wed, 18 Jun 2008 19:08:00 +0000 SAN DIEGO, California, June 18 /PRNewswire/ -- Germany is on the cutting edge in biotechnology R&D and is a top player in large- and clinical-scale production. Companies located in Germany are... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1243 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1243 Wed, 18 Jun 2008 19:00:00 +0000 SAN DIEGO, June 18 /PRNewswire/ -- Singapore has firmly established itself as a leading manufacturing hub in Asia with its strong track record, sophisticated infrastructure, superior IP protection... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1242 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1242 Wed, 18 Jun 2008 17:00:00 +0000 MUNICH, Germany, June 18 /PRNewswire/ -- A miraculous approach to psychotherapy conquers Europe: after having already helped numerous people in the German-speaking regions, Thomas Meyer, MD, the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1240 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1240 Wed, 18 Jun 2008 15:09:00 +0000 LOS ANGELES, California, June 18 /PRNewswire/ -- Canopus BioPharma, Inc. (OTC: CBIA), a biotechnology company developing pharmaceutical products and assay methods for patients suffering from... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1236 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1236 Wed, 18 Jun 2008 13:00:00 +0000 GENEVA, June 18 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that a Development and Licensing Agreement with Bionomics (ASX: BNO) was signed, under... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1237 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1237 Wed, 18 Jun 2008 13:00:00 +0000 TORONTO, Ontario, June 17 /PRNewswire/ -- The Schulich School of Business today released the first study to assess the impact of an influenza pandemic on individual companies. Presented today at the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1229 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1229 Tue, 17 Jun 2008 17:43:00 +0000 MILWAUKEE, Wisconsin, June 17 /PRNewswire/ -- The World Allergy Organization (WAO) will publish its first Report on the extent of allergy and chronic respiratory diseases worldwide on the 18 June... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1228 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1228 Tue, 17 Jun 2008 17:05:00 +0000 SAN DIEGO, June 17 /PRNewswire/ -- Singapore's investment of more than US$2.1 billion in the biomedical sciences sector has seeded one of the fastest growing bioclusters in the world. R&D... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1227 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1227 Tue, 17 Jun 2008 17:00:00 +0000 JERUSALEM and NEEDHAM, Massachusetts, June 17 /PRNewswire/ -- Oridion Systems Ltd. - (SWX: ORIDN) Significant findings from numerous medical research projects demonstrating the clinical benefit of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1219 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1219 Tue, 17 Jun 2008 06:00:00 +0000 LONDON, June 16 /PRNewswire/ -- Clinica - the world's leading news service for the medical technology industry - has learned that staff and visitors to London's Houses of Parliament have been at risk... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1217 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1217 Mon, 16 Jun 2008 16:42:00 +0000 PARIS and AACHEN, Germany, June 13 /PRNewswire/ -- Results from two phase III clinical studies of tapentadol immediate release tablets (IR) suggest a significantly improved... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1205 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1205 Fri, 13 Jun 2008 10:05:00 +0000 PARIS, June 13 /PRNewswire/ -- Seven-year rheumatoid arthritis (RA) data from open-label extension studies show that treatment with Abbott's HUMIRA(R) (adalimumab) resulted in clinical remission... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1202 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1202 Fri, 13 Jun 2008 07:00:00 +0000 PARIS, June 13 /PRNewswire/ -- New data announced today showed that treating patients with early, active rheumatoid arthritis (RA) with Abbott's HUMIRA(R) (adalimumab) and methotrexate (MTX)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1203 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1203 Fri, 13 Jun 2008 07:00:00 +0000 PARIS, June 13 /PRNewswire/ -- Abbott announced new data from the open-label extension of the ATLAS (Adalimumab Trial Evaluating Long-Term Efficacy and Safety in AS) phase III clinical trial, which... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1204 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1204 Fri, 13 Jun 2008 07:00:00 +0000 ZUG, Switzerland and CATANIA, Italy, June 12 /PRNewswire/ -- AmVac AG, a Swiss biopharmaceutical company based in Zug, is starting its first research cooperation program with Bayer Innovation GmbH... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1194 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1194 Thu, 12 Jun 2008 08:53:00 +0000 SEATTLE and PARIS, June 12 /PRNewswire/ -- Targeted Genetics Corporation (Nasdaq: TGEN) announced today that positive results of a Phase 1/2 clinical study demonstrate that tgAAC94,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1189 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1189 Thu, 12 Jun 2008 06:00:00 +0000 DEERFIELD, Illinois, June 11 /PRNewswire/ -- Baxter International Inc. (NYSE: BAX) announced publication in the June 12, 2008 issue of The New England Journal of Medicine (NEJM) of data demonstrating... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1188 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1188 Wed, 11 Jun 2008 22:36:00 +0000 LONDON, June 11 /PRNewswire/ -- Parents with dogs claim that since the arrival of their four-legged friend their children are less stressed and fitter. Research conducted by Mars Petcare reveals the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1184 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1184 Wed, 11 Jun 2008 07:00:00 +0000 BASEL, Switzerland, June 11 /PRNewswire/ -- A new meta-analysis of all 12 prospective, randomised, controlled studies in 2,301 cancer patients shows that treating anaemia with NeoRecormon(R) (epoetin... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1182 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1182 Wed, 11 Jun 2008 06:30:00 +0000 COPENHAGEN, Denmark, June 10 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today a Phase I/II study to evaluate a subcutaneous route of administration of ofatumumab (HuMax-CD20(R)) in rheumatoid... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1181 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1181 Tue, 10 Jun 2008 20:26:00 +0000 LONDON, June 10 /PRNewswire/ -- Despite renewed threats of an academic boycott of Israeli academics, more than 200 scientists from leading UK and European universities will gather in London next week... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1175 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1175 Tue, 10 Jun 2008 07:00:00 +0000 DUBAI, United Arab Emirates, June 9 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1168 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1168 Mon, 09 Jun 2008 10:00:00 +0000 AMSTERDAM, June 9 /PRNewswire/ -- 2collab (http://www.2collab.com), the research collaboration platform from Elsevier, the world's leading publisher of science, technology and medical (STM)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1167 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1167 Mon, 09 Jun 2008 09:20:00 +0000 BARCELONA, June 7 /PRNewswire/ -- ALK-Abelló today presented successful results from a new clinical trial, GT-12, designed to measure the impact of GRAZAX(R) on allergic rhinitis and allergic asthma.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1165 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1165 Sat, 07 Jun 2008 11:00:00 +0000 SAN FRANCISCO, California, June 6 /PRNewswire/ -- New results from the world's largest ever study of diabetes treatments show that intensive blood glucose (sugar) control using modified... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1164 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1164 Fri, 06 Jun 2008 22:00:00 +0000 EXTON, Pennsylvania, June 5 /PRNewswire/ -- BioTrends Research Group, Inc. is pleased to announce the release of TreatmentTrends(TM): European Nephrology Study II. The report is based on the results... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1160 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1160 Thu, 05 Jun 2008 21:22:00 +0000 LOS ANGELES, June 5 /PRNewswire/ -- The release of a World Health Organization/UNAIDS/UNICEF report on Monday documents appreciable global progress in the effort to deliver lifesaving antiretroviral... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1155 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1155 Thu, 05 Jun 2008 11:00:00 +0000 BASEL, Switzerland, June 5 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1153 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1153 Thu, 05 Jun 2008 07:15:00 +0000 GENEVA, Switzerland, June 5 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and its development partner ZymoGenetics, Inc. (NASDAQ: ZGEN) announced today the initiation of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1152 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1152 Thu, 05 Jun 2008 07:00:00 +0000 ISTANBUL, Turkey, June 4 /PRNewswire/ -- Over 350 of the world's leading scientific experts, policymakers and leading public health professionals from 67 countries convened today during the 8th... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1148 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1148 Wed, 04 Jun 2008 17:54:00 +0000 ANDOVER, England, June 4 /PRNewswire/ -- Stress continues to torment companies according to the Employee Benefits/ HSA Healthcare Research 2008. The survey, which is released today, finds that... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1143 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1143 Wed, 04 Jun 2008 10:11:00 +0000 KAISERAUGST, Switzerland, June 3 /PRNewswire/ -- If "an apple a day keeps the doctor away", a carrot a day might help to keep the sun burn away. That is the conclusion of a recently published... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1136 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1136 Tue, 03 Jun 2008 09:30:00 +0000 FRIMLEY, England, June 2 /PRNewswire/ -- http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1124 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1124 Mon, 02 Jun 2008 08:32:00 +0000 BERLIN, Germany, June 2 /PRNewswire/ -- Greater intra-ocular pressure (IOP) lowering benefit can be achieved for glaucoma patients treated with a fixed combination of bimatoprost and timolol... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1121 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1121 Mon, 02 Jun 2008 08:00:00 +0000 LONDON, June 2 /PRNewswire/ -- A new survey reveals more than three quarters - 84% - of the country's mums are unknowingly teaching their kids the incorrect routine when it comes to handling coughs... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1116 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1116 Mon, 02 Jun 2008 00:01:00 +0000 LONDON, June 2 /PRNewswire/ -- The UK will need to attract more highly skilled workers from abroad - both from the European Union and outside it - in order to secure the future of high technology,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1117 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1117 Mon, 02 Jun 2008 00:01:00 +0000 MUNICH, Germany and CHICAGO, May 31 /PRNewswire/ -- Treatment with the trifunctional antibody catumaxomab significantly prolongs puncture-free survival in patients with malignant ascites, according... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1115 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1115 Sat, 31 May 2008 19:00:00 +0000 BASEL, Switzerland, May 31 /PRNewswire/ -- Avastin (bevacizumab), significantly improves the time patients with metastatic breast cancer live without their disease getting worse ("progression-free... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1112 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1112 Sat, 31 May 2008 15:00:00 +0000 BASEL, Switzerland, May 31 /PRNewswire/ -- A wealth of new Avastin (bevacizumab) data will be presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1110 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1110 Sat, 31 May 2008 14:00:00 +0000 BASEL, Switzerland, May 31 /PRNewswire/ -- Adding Avastin (bevacizumab) to a combination of Tarceva (erlotinib) and chemotherapy significantly improves the time patients with metastatic pancreatic... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1111 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1111 Sat, 31 May 2008 14:00:00 +0000 STOCKHOLM, May 30 /PRNewswire/ -- The fragmented organization and management of lung cancer diagnosis and care in many European countries are exacerbating already poor survival rates amongst patients... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1108 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1108 Fri, 30 May 2008 18:07:00 +0000 CHICAGO, May 30 /PRNewswire/ -- Agendia BV, a world leader in the rapidly evolving field of molecular diagnostics, announced today that data from two studies involving its MammaPrint(R) breast cancer... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1107 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1107 Fri, 30 May 2008 16:44:00 +0000 BASEL, Switzerland, May 30 /PRNewswire/ -- Data presented at the largest oncology meeting in the world, the American Society of Clinical Oncology (ASCO), shows that the costs of managing side effects... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1106 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1106 Fri, 30 May 2008 15:00:00 +0000 COPENHAGEN, Denmark, May 30 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today it has initiated a Phase I/II study of zalutumumab (HuMax-EGFr(TM)) in combination with irinotecan chemotherapy to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1103 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1103 Fri, 30 May 2008 08:31:00 +0000 AMSTERDAM, May 30 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that positive interim data from its pivotal clinical... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1102 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1102 Fri, 30 May 2008 06:00:00 +0000 TURNHOUT, Belgium, May 29 /PRNewswire/ -- New phase III data for RESOLOR(R) (prucalopride) published today in The New England Journal of Medicine (NEJM) shows statistically and clinically significant... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1099 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1099 Thu, 29 May 2008 17:35:00 +0000 EDMONTON, Canada, May 29 /PRNewswire/ -- Isotechnika Inc. announced today that voclosporin is positioned to enter a Phase 1 clinical trial as the drug utilized in the CINATRA(TM) Drug Coated... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1095 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1095 Thu, 29 May 2008 14:00:00 +0000 COPENHAGEN, Denmark, May 29 /PRNewswire/ -- Genmab A/S (OMX: GEN) reports today that the last patient to be included in the planned interim analysis (N=132 patients) in the pivotal Phase III... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1093 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1093 Thu, 29 May 2008 12:23:00 +0000 AMSTERDAM, May 29 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma announces today the clinical development collaboration for its lead product ATIR(TM) with Dr. Stephan Mielke and Professor... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1091 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1091 Thu, 29 May 2008 10:40:00 +0000 LONDON, May 29 /PRNewswire/ -- Today, on the occasion of World Digestive Health Day (WDHD), the World Gastroenterology Organisation (WGO) has launched a year-long campaign titled 'Optimum Health and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1089 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1089 Thu, 29 May 2008 00:01:00 +0000 MAIDENHEAD, England, May 28 /PRNewswire/ -- The National Institute for Health and Clinical Excellence (NICE) has today recommended adalimumab (HUMIRA) as one of the treatment options for people with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1082 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1082 Wed, 28 May 2008 16:47:00 +0000 TIRAT CARMEL, Israel, May 28 /PRNewswire/ -- InSightec Ltd. announced today that the U.S. Food and Drug Administration (FDA) cleared the company to conduct a clinical trial to evaluate the efficacy... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1080 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1080 Wed, 28 May 2008 13:00:00 +0000 LONDON, May 29 /PRNewswire/ -- More northern women feel bloating and gurgling than their southern counterparts with up to 70% of them likely to experience it at any one time, according to a TNS... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1086 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1086 Wed, 28 May 2008 06:00:00 +0000 WASHINGTON DC, May 27 /PRNewswire/ -- Bavarian Nordic, the Danish-based biopharmaceutical company, has initiated a Phase I/II clinical study with its HIV vaccine candidate: MVA-BN(R) HIV... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1074 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1074 Tue, 27 May 2008 15:44:00 +0000 KVISTGÅRD, Denmark, May 27 /PRNewswire/ -- Bavarian Nordic has initiated Phase I/II clinical study with its HIV vaccine candidate: MVA-BN(R) HIV multiantigen. A Phase I/II safety and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1071 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1071 Tue, 27 May 2008 09:40:00 +0000 BURGESS HILL, England, May 27 /PRNewswire/ -- As the National Institute for Health and Clinical Excellence (NICE) is set to announce new guidance (28th May) recommending regular blood... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1068 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1068 Tue, 27 May 2008 00:01:00 +0000 AMSTERDAM, The Netherlands, May 26 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it obtained a Cooperative... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1067 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1067 Mon, 26 May 2008 06:00:00 +0000 BARCELONA, Spain, May 25 /PRNewswire/ -- In a first-of-its-kind study in osteoporosis, one in four women surveyed from Europe, North America, and Australia reported having one or more bone fractures... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1066 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1066 Sun, 25 May 2008 11:45:00 +0000 ISTANBUL, Turkey, May 23 /PRNewswire/ -- New data from key clinical trials presented today at the 5th European Academy of Dermatology and Venereology (EADV) Spring Symposium in Istanbul,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1061 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1061 Fri, 23 May 2008 08:30:00 +0000 AMSTERDAM, The Netherlands, May 22 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it obtained a license from La... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1055 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1055 Thu, 22 May 2008 06:00:00 +0000 ABBOTT PARK, Illinois, May 21 /PRNewswire/ -- Results from an open-label extension study of two Abbott pivotal studies, CHARM and GAIN, demonstrate that adult moderate-to-severe Crohn's... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1053 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1053 Wed, 21 May 2008 17:15:00 +0000 HILDEN, Germany, May 21 /PRNewswire/ -- Long-term data from a study published in the International Journal of Cancer show that women screened only with a human papillomavirus (HPV) DNA test are... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1048 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1048 Wed, 21 May 2008 09:25:00 +0000 WASHINGTON, May 20 /PRNewswire/ -- A major study published today in Nature Nanotechnology suggests some forms of carbon nanotubes -- a poster child for the "nanotechnology revolution" -- could be as... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1045 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1045 Tue, 20 May 2008 18:00:00 +0000 LONDON, May 20 /PRNewswire/ -- Eisai Europe Limited, (Headquarters: London, Chairman and CEO Yutaka Tsuchiya) today announced publication of the results of a major study of its new anti-epileptic... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1039 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1039 Tue, 20 May 2008 10:06:00 +0000 HILDEN, Germany, May 20 /PRNewswire/ -- Long-term data from a study published in the International Journal of Cancer show that women screened only with a human papillomavirus (HPV) DNA test are... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1037 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1037 Tue, 20 May 2008 09:00:00 +0000 BRISTOL, England, May 20 /PRNewswire/ -- Women who fear they are sexually dysfunctional will be relieved by the preliminary results of a new study that demonstrates that effective pelvic floor... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1035 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1035 Tue, 20 May 2008 08:00:00 +0000 FRIMLEY, England, May 20 /PRNewswire/ -- Tasigna(R) (nilotinib) is now available in the UK as a new option to treat adult patients who are intolerant or resistant to previous therapies for... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1034 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1034 Mon, 19 May 2008 09:00:00 +0000 GENEVA, Switzerland, May 19 /PRNewswire/ -- The World Hepatitis Alliance, a newly formed Non-Governmental Organisation, today called on governments around the world to do more to drive improvements... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1024 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1024 Mon, 19 May 2008 08:00:00 +0000 LONDON, May 16 /PRNewswire/ -- Eisai Europe Ltd. The investigational chemotherapeutic agent eribulin mesylate (E7389) demonstrated activity in a heavily pretreated population of women with locally... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1015 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1015 Fri, 16 May 2008 07:00:00 +0000 BASEL, Switzerland, May 16 /PRNewswire/ -- Patients with breast or colorectal cancer, two of the world's most common cancers, can expect further treatment advances with Avastin(R) (bevacizumab) and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1013 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1013 Fri, 16 May 2008 02:00:00 +0000 LONDON, May 16 /PRNewswire/ -- Eight out of ten undergraduates would be proud to work in the NHS, a NHS Careers survey revealed today. Although 78% still said the NHS would not be their first choice... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1012 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1012 Fri, 16 May 2008 00:01:00 +0000 SUNNYVALE, California, May 15 /PRNewswire/ -- BARRX Medical, Inc., the global technology leader for treating precancerous conditions of the digestive tract, today announced that 90.2 percent of the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1011 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1011 Thu, 15 May 2008 23:07:00 +0000 PARIS, May 15 /PRNewswire/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that findings from the landmark ATHENA study showed that Multaq(R) (dronedarone), a potential therapy for... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1006 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1006 Thu, 15 May 2008 17:45:00 +0000 LONDON, May 15 /PRNewswire/ -- Whilst a controversial chemical found in most plastic baby bottles has been making headlines in North America, a poll by Bounty, the UK's biggest parenting club,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1005 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1005 Thu, 15 May 2008 16:57:00 +0000 HIGH WYCOMBE, England, May 15 /PRNewswire/ -- A new clinical study published today in Biological Psychiatry adds weight to the growing body of evidence that adults suffering from attention... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1002 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1002 Thu, 15 May 2008 11:12:00 +0000 NICE, France, May 15 /PRNewswire/ -- New two-year data from the REACH Registry presented at the European Stroke Congress, highlight that among those who die after a stroke the vast majority (73%)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1001 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1001 Thu, 15 May 2008 10:53:00 +0000 MAIDENHEAD, England, May 14 /PRNewswire/ -- Data presented at the 26th annual meeting of the European Society for Paediatric Infectious Diseases (ESPID) in Graz, Austria, provide additional evidence... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/988 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/988 Wed, 14 May 2008 08:30:00 +0000 LEUVEN, Belgium, May 13 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on innovative treatments for vascular disease, eye disease and cancer, is today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/983 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/983 Tue, 13 May 2008 16:40:00 +0000 LONDON, May 12 /PRNewswire/ -- If you want a beaming smile but your all important brushing and flossing still leaves you frowning, take advice from Chief Dental Officer, Barry Cockcroft, on keeping... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/974 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/974 Mon, 12 May 2008 16:06:00 +0000 LONDON, May 9 /PRNewswire/ -- The Royal Pharmaceutical Society of Great Britain (RPSGB) today called for the Government to undertake impact assessments in its planning of polyclinics. Director... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/958 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/958 Fri, 09 May 2008 12:27:00 +0000 HONG KONG, May 8 /PRNewswire/ -- Twelve-month follow-up data from both a randomized pilot study and the real-world registry use of OrbusNeich's Genous Bio-engineered R stent, the world's first... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/951 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/951 Thu, 08 May 2008 13:00:00 +0000 LONDON, May 9 /PRNewswire/ -- A study published in the May 2008 issue of the peer-reviewed Journal of Urology demonstrates that the prostate cancer gene 3 (PCA3) can be used to detect and stratify... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/953 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/953 Thu, 08 May 2008 11:48:00 +0000 INGELHEIM, Germany, May 7 /PRNewswire/ -- Data announced at this week's American College of Obstetricians and Gynecologists (ACOG) annual clinical meeting suggest that up to one in ten women are... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/941 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/941 Wed, 07 May 2008 12:30:00 +0000 LONDON, May 6 /PRNewswire/ -- The Work Foundation today publishes a new essay that asks what is 'meaningful work', why more people seem to be seeking it, and what employers can do to make work more... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/920 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/920 Tue, 06 May 2008 00:01:00 +0000 GENEVA, Switzerland, May 5 /PRNewswire/ -- Final results of the first three-year prospective efficacy and safety study in moderate-to-severe chronic plaque psoriasis were recently published in the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/915 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/915 Mon, 05 May 2008 09:30:00 +0000 PARIS, May 1 /PRNewswire/ -- A new analysis of data from the landmark Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering Arm (ASCOT-BPLA) published today in Diabetes Care has... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/908 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/908 Thu, 01 May 2008 12:04:00 +0000 LUDWIGSHAFEN, Germany, April 30 /PRNewswire/ -- Few spices are as treasured and avoided! A clove of garlic is both tasty and healthy, but after you eat it, don't be surprised if even your friends... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/899 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/899 Wed, 30 Apr 2008 11:30:00 +0000 PHILADELPHIA and LONDON, April 29 /PRNewswire/ -- The Scientific business of Thomson Reuters today announced the launch of a new biomarkers report, "Establishing the Standards in Biomarker... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/897 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/897 Tue, 29 Apr 2008 17:40:00 +0000 ANN ARBOR, Michigan, April 28 /PRNewswire/ -- Terumo Heart, Inc. announced a presentation at the recent ISHLT meeting in Boston. The presentation entitled "Long Term Circulatory Support with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/887 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/887 Mon, 28 Apr 2008 14:05:00 +0000 DUBLIN, Ireland and GREENVILLE, North Carolina, April 28 /PRNewswire/ -- East Carolina University reveals the results of a 6-month randomized, controlled study that confirms positive health benefits... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/886 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/886 Mon, 28 Apr 2008 14:00:00 +0000 REHOVOT, Israel and JERSEY CITY, New Jersey, April 28 /PRNewswire/ -- Rosetta Genomics (Nasdaq:ROSG), a leading developer of microRNA-based diagnostics and therapeutics, announced today that it... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/885 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/885 Mon, 28 Apr 2008 13:30:00 +0000 VEENENDAAL, The Netherlands, April 28 /PRNewswire/ -- Nucletron, a knowledge-based leader in radiation oncology, today announced the introduction of Oncentra(R) Brachy*, a comprehensive volume-based... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/935 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/935 Mon, 28 Apr 2008 09:00:00 +0000 VEENENDAAL, The Netherlands, April 28 /PRNewswire/ -- Nucletron, a knowledge-based leader in radiation oncology, today announced the introduction of Oncentra(R) Brachy*, a comprehensive volume-based... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/883 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/883 Mon, 28 Apr 2008 08:00:00 +0000 MILAN, Italy, April 27 /PRNewswire/ -- At today's sessions of this, the final day of the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), leading hepatologists... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/877 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/877 Sun, 27 Apr 2008 05:00:00 +0000 WELWYN GARDEN CITY, England, April 27 /PRNewswire/ -- Roche's investigational treatment for hepatitis C, R1626, has shown an impressive end-of-treatment response rate when given in combination with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/876 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/876 Sun, 27 Apr 2008 00:01:00 +0000 BASEL, Switzerland, April 26 /PRNewswire/ -- Roche's investigational treatment for hepatitis C, R1626, has shown an impressive end-of-treatment response rate when given in combination with PEGASYS(R)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/874 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/874 Sat, 26 Apr 2008 17:15:00 +0000 MILAN, April 26 /PRNewswire/ -- At today's sessions of the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), experts reported advances in basic research that have... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/872 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/872 Sat, 26 Apr 2008 05:00:00 +0000 PRINCETON, New Jersey and MILAN, Italy, April 25 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces the results of a 4-week Phase 1 clinical trial evaluating two oral dose levels of R7128 in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/870 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/870 Fri, 25 Apr 2008 16:30:00 +0000 MILAN, April 25 /PRNewswire/ -- Scientists presenting at today's sessions of the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL) reported encouraging findings... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/864 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/864 Fri, 25 Apr 2008 05:00:00 +0000 PRINCETON, New Jersey and MILAN, Italy, April 24 /PRNewswire/ -- -- Two 4-week cohorts will be enrolled to evaluate R7128 1500mg BID in HCV genotypes 2 and 3 prior non-responders and R7128 1000mg BID... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/858 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/858 Thu, 24 Apr 2008 14:16:00 +0000 LIVERPOOL, England, April 24 /PRNewswire/ -- New pan-European data presented today at the British Society of Rheumatology's annual meeting in Liverpool demonstrate that patients treated with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/855 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/855 Thu, 24 Apr 2008 10:00:00 +0000 MILAN, April 24 /PRNewswire/ -- Data presented at today's sessions of the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL) further confirm that nonalcoholic fatty... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/849 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/849 Thu, 24 Apr 2008 05:00:00 +0000 FALLS CHURCH, Virginia and CUMMAQUID, Massachusetts, April 23 /PRNewswire/ -- FDAnews and Industry Directions Inc., in close association with research analysis partner Cambashi Ltd, today invited... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/847 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/847 Wed, 23 Apr 2008 20:07:00 +0000 MILAN, April 23 /PRNewswire/ -- More than 6,000 physicians and scientists from around the world gathered today in this historic Italian city to attend the opening sessions of the 43rd Annual Meeting... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/841 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/841 Wed, 23 Apr 2008 10:30:00 +0000 CALGARY, Canada, April 22 /PRNewswire/ -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has completed dosing of its Phase 1a safety, tolerability... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/835 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/835 Tue, 22 Apr 2008 14:30:00 +0000 CAMBRIDGE, England, April 21 /PRNewswire/ -- Beremans Ltd (http://www.beremans.com), a Cambridge (UK)-based company that provides business intelligence services for the Life Sciences sector,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/826 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/826 Mon, 21 Apr 2008 15:29:00 +0000 AACHEN, Germany, April 21 /PRNewswire/ -- Submissions for the 2008 EFIC-Grunenthal Grant will be accepted by 31st May 2008. This annual grant of EUR 100,000 is awarded in co-operation with the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/825 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/825 Mon, 21 Apr 2008 14:35:00 +0000 CALGARY, Canada, April 16 /PRNewswire/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that Prof. Alan Melcher and his research group at St. James's University... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/804 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/804 Wed, 16 Apr 2008 11:30:00 +0000 GENEVA, April 16 /PRNewswire/ -- Merck Serono and its US affiliate EMD Serono, Inc., both part of Merck KGaA, Darmstadt, Germany, announced today a planned expansion of EMD Serono's US presence with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/803 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/803 Wed, 16 Apr 2008 11:25:00 +0000 DUBLIN, April 15 /PRNewswire/ -- It is commonly known that many children get facial rashes, while teenagers tend to have acne - but as a person ages, their skin is supposed to clear up. However,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/793 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/793 Tue, 15 Apr 2008 09:00:00 +0000 CALGARY, Canada, April 14 /PRNewswire/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) has completed patient enrolment in the dose escalation portion of its U.K. clinical trial to... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/790 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/790 Mon, 14 Apr 2008 18:37:00 +0000 LONDON, April 14 /PRNewswire/ -- A Group of people with multiple sclerosis (MS) in Yorkshire are being denied access to a vital drug that has been proved to be the most effective treatment for their... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/787 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/787 Mon, 14 Apr 2008 15:57:00 +0000 DÜSSELDORF, Germany, April 14 /PRNewswire/ -- The rating agency Standard & Poor's has raised the Gerresheimer Group's rating from BB to BB+ with "Outlook stable". This means that Gerresheimer is... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/779 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/779 Mon, 14 Apr 2008 06:00:00 +0000 LONDON, April 14 /PRNewswire/ -- Over five million of the 13 million hay fever sufferers across Britain could be taking inappropriate medicines, putting their health at risk. The Royal Pharmaceutical... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/777 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/777 Mon, 14 Apr 2008 00:01:00 +0000 SAN DIEGO, California, April 11 /PRNewswire/ -- Ortho Biotech Oncology Research & Development (ORD), a unit of Johnson & Johnson Pharmaceutical Research & Development, L.L.C., will... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/773 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/773 Fri, 11 Apr 2008 16:00:00 +0000 CHELTENHAM, England, April 11 /PRNewswire/ -- Results from a survey released today by national sick children's charity, WellChild, shows that lawyers and academics raised the most money for... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/769 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/769 Fri, 11 Apr 2008 08:00:00 +0000 TOKYO, Japan, April 11 /PRNewswire/ -- E2007 (perampanel) is a first-in-class, orally administered, highly selective non-competitive AMPA-type glutamate receptor antagonist, in development by Eisai... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/768 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/768 Fri, 11 Apr 2008 07:06:00 +0000 RESEARCH TRIANGLE PARK, North Carolina, April 10 /PRNewswire/ -- Quintiles Transnational Corp. today announced that an independently conducted study of clinical investigator sites across Europe... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/766 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/766 Thu, 10 Apr 2008 19:42:00 +0000 LONDON, April 10 /PRNewswire/ -- According to a new report from University College London entitled Periodontal Disease in Modern Day Britain, over half of all adults in Britain are suffering a dental... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/763 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/763 Thu, 10 Apr 2008 11:19:00 +0000 ISTANBUL, Turkey, April 10 /PRNewswire/ -- Nearly 60,000 women aged 55 years and older have enrolled in a landmark, multi-national study that will focus on the management of osteoporosis across the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/760 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/760 Thu, 10 Apr 2008 00:01:00 +0000 EVRY, France, April 9 /PRNewswire/ -- Novagali Pharma, an ophthalmic specialty pharmaceutical company announces the commercial launch in France of its first product Cationorm(R). This cationic... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/752 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/752 Wed, 09 Apr 2008 07:00:00 +0000 LONDON, April 7 /PRNewswire/ -- Scientists have today announced that mice given the equivalent of six to eight cups of coffee a day were protected from developing the animal model for multiple... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/742 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/742 Mon, 07 Apr 2008 20:45:00 +0000 LONDON, April 7 /PRNewswire/ -- Silence Therapeutics plc (AIM:SLN) Europe's leading RNAi-focused biotechnology company, today comments on two recent journal articles: Nature(1) "Sequence-and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/735 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/735 Mon, 07 Apr 2008 07:00:00 +0000 SAN DIEGO, California, April 5 /PRNewswire/ -- Looking for foods that can help reduce the risk of heart disease? Consider the latest almond nutrition research presented at the annual Experimental... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/732 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/732 Sat, 05 Apr 2008 07:00:00 +0000 YOQNEAM, Israel and SAN RAMON, California, April 3 /PRNewswire/ -- Results of an independent multi-treatment clinical study of the UltraShape(R) Contour I, the first clinically proven non-invasive... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/725 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/725 Thu, 03 Apr 2008 12:00:00 +0000 WASHINGTON DC, April 2 /PRNewswire/ -- Bavarian Nordic, the Danish-based biopharmaceutical company, recently published its 2007 Annual Report. Below is an extract of the most significant matters in... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/722 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/722 Wed, 02 Apr 2008 13:00:00 +0000 CHICAGO, April 2 /PRNewswire/ -- Final six-month, follow-up patient data presented yesterday during the late-breaking clinical trial sessions at the American College of Cardiology, suggest MyoCell(R)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/661 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/661 Wed, 02 Apr 2008 09:00:00 +0000 ANDOVER, England, April 1 /PRNewswire/ -- HSA's Annual Dental Survey 2008 has revealed that 1 in 5 of UK adults have put off visiting the dentist because they are concerned about the cost. The... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/653 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/653 Tue, 01 Apr 2008 08:25:00 +0000 LONDON, March 31 /PRNewswire/ -- CRESTOR(TM) (rosuvastatin) is the only statin to show regression of coronary atherosclerosis in a major clinical study. That result, which was based on intravascular... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/644 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/644 Mon, 31 Mar 2008 16:00:00 +0000 LONDON, March 31 /PRNewswire/ -- Lowering the blood pressure of elderly patients could cut their total mortality by a fifth and their rate of cardiovascular events by a third, according to a new... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/645 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/645 Mon, 31 Mar 2008 16:00:00 +0000 BOULDER, Colorado, March 31 /PRNewswire/ -- Elite athletes travel -- a lot. And when competitive professionals arrive at their destination, they're on the field within hours. In professional sports,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/642 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/642 Mon, 31 Mar 2008 14:00:00 +0000 LONDON, April 1 /PRNewswire/ -- An expert report released today recommends that patients taking antibiotics, especially those being treated in hospital, should take a daily probiotic drink with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/637 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/637 Mon, 31 Mar 2008 07:00:00 +0000 LONDON, March 28 /PRNewswire/ -- It's fair to say that UK women now have more choice than ever when it comes facial anti-ageing solutions. From innovative cosmetic surgery procedures to topical so... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/633 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/633 Fri, 28 Mar 2008 08:00:00 +0000 CARLSBAD, California, March 27 /PRNewswire/ -- Ablation Frontiers, Inc., a privately held medical device company, announced today that a poster at the American College of Cardiology (ACC) Scientific... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/631 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/631 Thu, 27 Mar 2008 15:26:00 +0000 FREISING-WEIHENSTEPHAN, Germany, March 27 /PRNewswire/ -- Pieris AG, a bio-pharmaceutical company developing Anticalins(R), a novel class of targeted human protein therapeutics, announced today the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/626 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/626 Thu, 27 Mar 2008 10:00:00 +0000 MILAN, Italy, March 27 /PRNewswire/ -- Data from a Phase III study presented at the 23rd Annual European Association of Urology Congress demonstrated that the investigational GnRH blocker, degarelix,... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/627 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/627 Thu, 27 Mar 2008 10:00:00 +0000 LONDON, March 27 /PRNewswire/ -- Responding to guidance issued today by the Medicines and Healthcare products Regulatory Agency (MHRA), advising that cough and cold treatments should not be used for... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/625 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/625 Thu, 27 Mar 2008 09:36:00 +0000 CALGARY, Canada, March 26 /PRNewswire/ -- SemBioSys Genetics Inc. (TSX: SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/615 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/615 Wed, 26 Mar 2008 11:00:00 +0000 LONDON, March 26 /PRNewswire/ -- Millions of British men and women are at risk at work today because of a lack of safety training, the biggest survey ever carried out by the British Safety Council... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/612 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/612 Wed, 26 Mar 2008 08:00:00 +0000 MANCHESTER, England, March 20 /PRNewswire/ -- Two leading skincare experts will be alerting adults in and around Manchester to the signs and symptoms of rosacea and how to regain control of their... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/603 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/603 Thu, 20 Mar 2008 15:27:00 +0000 LONDON, March 19 /PRNewswire/ -- New clinical data from a study of 570 men published in the peer-reviewed Journal of Urology(1) support the use of PROGENSA PCA3 as a tool for diagnosing prostate... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/595 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/595 Wed, 19 Mar 2008 11:10:00 +0000 DES MOINES, Iowa, March 18 /PRNewswire/ -- New oil testing results confirm a new, improved soybean oil trait from DuPont will deliver increased nutritional benefits with broader applications than... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/591 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/591 Tue, 18 Mar 2008 18:14:00 +0000 HORSHOLM, Denmark, March 17 /PRNewswire/ -- ALK-Abelló yesterday presented successful Phase III clinical study results with GRAZAX(R) in children at the American Academy of Allergy, Asthma &... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/584 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/584 Mon, 17 Mar 2008 10:00:00 +0000 HORSHOLM, Denmark, March 17 /PRNewswire/ -- - Results Show Highly Significant Effect on Rhinoconjunctivitis (Hay Fever) and Asthma Symptoms in Children from age 5 to 16 Years-old http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/716 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/716 Mon, 17 Mar 2008 10:00:00 +0000 MADRID, March 17 /PRNewswire/ -- Leading rheumatologists have highlighted the importance of early intervention in rheumatoid arthritis to achieve clinical remission, a key goal in the management of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/581 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/581 Mon, 17 Mar 2008 07:00:00 +0000 MADRID, March 17 /PRNewswire/ -- Data presented today from the first ever Phase III study using a biological treatment in children and adolescents with plaque psoriasis indicate that etanercept... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/582 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/582 Mon, 17 Mar 2008 07:00:00 +0000 MADRID, March 17 /PRNewswire/ -- Data presented today from the first ever Phase III study using a biological treatment in children and adolescents with plaque psoriasis indicate that etanercept... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/713 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/713 Mon, 17 Mar 2008 07:00:00 +0000 MADRID, March 17 /PRNewswire/ -- - Improved Remission Rates Lead to Fewer Sick Days and Increased Productivity at Work http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/714 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/714 Mon, 17 Mar 2008 07:00:00 +0000 STOCKHOLM, Sweden, March 14 /PRNewswire/ -- Diamyd Medical AB (http://www.omxgroup.com, ticker: DIAM B; http://www.otcqx.com, ticker DMYDY). The FDA has given Diamyd Medical permission to start... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/707 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/707 Fri, 14 Mar 2008 13:06:00 +0000 BRADFORD, England, March 13 /PRNewswire/ -- Health researchers at the University of Bradford have welcomed the GBP500,000 donation announced by best-selling author Terry Pratchett today (Thursday... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/701 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/701 Thu, 13 Mar 2008 16:20:00 +0000 ZURICH, Switzerland and FAIRFIELD, New Jersey, March 13 /PRNewswire/ -- "The new Stonegate Report about Unigene confirms that we are uniquely positioned as the only biopharma company that... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/699 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/699 Thu, 13 Mar 2008 12:17:00 +0000 LONDON, March 13 /PRNewswire/ -- Two-thirds of veterinary professionals believe that pet obesity is the single biggest health issue facing domestic animals throughout Europe, with 96 per cent of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/685 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/685 Thu, 13 Mar 2008 08:00:00 +0000 BRUSSELS and ALEXANDRIA, Egypt, March 13 /PRNewswire/ -- Over 246 million people live with diabetes across the world and 4.4 million of those people live in Egypt. Poor diabetes control can lead... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/694 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/694 Thu, 13 Mar 2008 08:00:00 +0000 HELSINKI, Finland, March 12 /PRNewswire/ -- - Prove-it Herpes Offers Considerable Cost Savings for Healthcare Industry by Identifying Eight Herpesviruses Simultaneously http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/690 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/690 Wed, 12 Mar 2008 07:30:00 +0000 KINNELON, New Jersey and ALEXANDRIA, Louisiana, March 11 /PRNewswire/ -- Life Recovery Systems, HD, LLC announced today approval by the Food and Drug Administration (FDA) of an... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/687 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/687 Tue, 11 Mar 2008 16:00:00 +0000 LONDON, March 7 /PRNewswire/ -- Cannabis-derived medicines may one day be used in the treatment of Alzheimer's disease which affects 417,000 people in the UK. Professor Raphael Mechoulam of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/673 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/673 Fri, 07 Mar 2008 18:20:00 +0000 READING, England, March 7 /PRNewswire/ -- - Bimuno(R) Shown to Significantly Increase the Best Health-Promoting 'Good' gut Bacteria, Bifidobacteria, That Help Protect Against Illness... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/669 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/669 Fri, 07 Mar 2008 13:00:00 +0000 MANCHESTER, England, March 7 /PRNewswire/ -- - A Staggering GBP120,000 Spent on Smoking Cigarettes http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/671 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/671 Fri, 07 Mar 2008 11:46:00 +0000 PARIS, February 4 /PRNewswire/ -- A Working Group of representatives from seven international health-care organizations call for improved blood pressure (BP) goal rate levels of patients with... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/575 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/575 Mon, 04 Feb 2008 09:00:00 +0000 VEENENDAAL, The Netherlands, February 4 /PRNewswire/ -- Nucletron BV and clinicians at The Cancer Centre, Northern Ireland, proudly report the first IMRT clinical treatment within the Conventional... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/573 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/573 Mon, 04 Feb 2008 08:00:00 +0000 CALGARY, Canada, February 4 /PRNewswire/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ('Oncolytics') reported today that Dr. Kevin Harrington and his research group at The Institute of Cancer... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/571 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/571 Mon, 04 Feb 2008 05:01:00 +0000 LONDON, February 1 /PRNewswire/ -- The Disciplinary Committee of the Royal College of Veterinary Surgeons has this week refused an application for restoration to the Register from a former... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/570 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/570 Fri, 01 Feb 2008 18:24:00 +0000 BADEN, Austria, February 1 /PRNewswire/ -- A workshop organized by the International Scientific Working Group on Tick-borne Encephalitis (ISW-TBE), held in Baden/Vienna, aims at raising public... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/566 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/566 Fri, 01 Feb 2008 09:00:00 +0000 LONDON, February 1 /PRNewswire/ -- It is not only joy and goodwill that epitomise Christmas and the New Year. It is also stress, unrealistic expectations, letdowns, tension and, not least, drinking... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/564 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/564 Fri, 01 Feb 2008 08:00:00 +0000 WORCESTER, Massachusetts, February 1 /PRNewswire/ -- ENDORSE multinational study (Epidemiologic International Day for the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/563 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/563 Fri, 01 Feb 2008 00:01:00 +0000 LONDON, January 31 /PRNewswire/ -- Responding to news today that 1 million prescriptions per year are now made for obesity drugs, the Royal Pharmaceutical Society of Great Britain (RPSGB) has called... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/562 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/562 Thu, 31 Jan 2008 15:15:00 +0000 AMSTERDAM, January 31 /PRNewswire/ -- Oncology focused biopharmaceutical product development company Kiadis Pharma announced today that it has successfully finalized its Rhitol(TM) Phase II clinical... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/561 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/561 Thu, 31 Jan 2008 12:41:00 +0000 CALGARY, Canada, January 31 /PRNewswire/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that it has met the initial criteria to proceed to full enrolment in its U.S.... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/558 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/558 Thu, 31 Jan 2008 07:01:00 +0000